Frequencies for first 10,000 rows of pt variable in reac2010q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 8 0.08 0.08 ABDOMINAL ABSCESS | 1 0.01 0.09 ABDOMINAL ADHESIONS | 1 0.01 0.10 ABDOMINAL COMPARTMENT SYNDROME | 1 0.01 0.11 ABDOMINAL DISCOMFORT | 7 0.07 0.18 ABDOMINAL DISTENSION | 10 0.10 0.28 ABDOMINAL HERNIA | 2 0.02 0.30 ABDOMINAL INFECTION | 1 0.01 0.31 ABDOMINAL PAIN | 25 0.25 0.56 ABDOMINAL PAIN LOWER | 2 0.02 0.58 ABDOMINAL PAIN UPPER | 17 0.17 0.75 ABDOMINAL TENDERNESS | 2 0.02 0.77 ABDOMINAL WALL DISORDER | 1 0.01 0.78 ABNORMAL BEHAVIOUR | 5 0.05 0.83 ABNORMAL DREAMS | 3 0.03 0.86 ABNORMAL SENSATION IN EYE | 1 0.01 0.87 ABORTION | 1 0.01 0.88 ABORTION INDUCED | 3 0.03 0.91 ABORTION MISSED | 2 0.02 0.93 ABORTION SPONTANEOUS | 7 0.07 1.00 ABSCESS | 4 0.04 1.04 ABSCESS INTESTINAL | 1 0.01 1.05 ABSCESS JAW | 1 0.01 1.06 ABSCESS LIMB | 2 0.02 1.08 ACCIDENTAL DRUG INTAKE BY CHILD | 2 0.02 1.10 ACCIDENTAL EXPOSURE | 1 0.01 1.11 ACCIDENTAL OVERDOSE | 4 0.04 1.15 ACNE | 5 0.05 1.20 ACTINIC KERATOSIS | 1 0.01 1.21 ACTINOMYCOSIS | 1 0.01 1.22 ACTIVITIES OF DAILY LIVING IMPAIRED | 2 0.02 1.24 ACUTE ABDOMEN | 1 0.01 1.25 ACUTE CORONARY SYNDROME | 1 0.01 1.26 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 1.27 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 3 0.03 1.30 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 1 0.01 1.31 ACUTE GRAFT VERSUS HOST DISEASE IN LI.. | 1 0.01 1.32 ACUTE HEPATIC FAILURE | 2 0.02 1.34 ACUTE LEUKAEMIA | 1 0.01 1.35 ACUTE MYELOID LEUKAEMIA | 3 0.03 1.38 ACUTE MYOCARDIAL INFARCTION | 5 0.05 1.43 ACUTE RESPIRATORY DISTRESS SYNDROME | 5 0.05 1.48 ACUTE RESPIRATORY FAILURE | 3 0.03 1.51 ADENOCARCINOMA | 1 0.01 1.52 ADENOMA BENIGN | 1 0.01 1.53 ADHESION | 1 0.01 1.54 ADNEXA UTERI MASS | 1 0.01 1.55 ADRENAL INSUFFICIENCY | 1 0.01 1.56 ADRENAL SUPPRESSION | 1 0.01 1.57 ADVERSE DRUG REACTION | 5 0.05 1.62 ADVERSE EVENT | 7 0.07 1.69 ADVERSE REACTION | 1 0.01 1.70 AFFECTIVE DISORDER | 1 0.01 1.71 AGEUSIA | 1 0.01 1.72 AGGRESSION | 17 0.17 1.89 AGITATION | 17 0.17 2.06 AGORAPHOBIA | 2 0.02 2.08 AGRANULOCYTOSIS | 2 0.02 2.10 AKATHISIA | 1 0.01 2.11 ALANINE AMINOTRANSFERASE INCREASED | 6 0.06 2.17 ALLERGY TO ANIMAL | 1 0.01 2.18 ALLODYNIA | 1 0.01 2.19 ALOPECIA | 13 0.13 2.32 ALOPECIA TOTALIS | 1 0.01 2.33 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 2.34 ALTERED STATE OF CONSCIOUSNESS | 4 0.04 2.38 ALTERED VISUAL DEPTH PERCEPTION | 1 0.01 2.39 ALVEOLITIS ALLERGIC | 1 0.01 2.40 AMBLYOPIA | 1 0.01 2.41 AMENORRHOEA | 4 0.04 2.45 AMMONIA INCREASED | 1 0.01 2.46 AMNESIA | 7 0.07 2.53 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.54 ANAEMIA | 37 0.37 2.91 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.92 ANAEMIA OF CHRONIC DISEASE | 1 0.01 2.93 ANAESTHETIC COMPLICATION | 1 0.01 2.94 ANAL FISTULA | 3 0.03 2.97 ANAL PRURITUS | 1 0.01 2.98 ANAPHYLACTIC REACTION | 9 0.09 3.07 ANAPHYLACTIC SHOCK | 7 0.07 3.14 ANAPHYLACTOID SYNDROME OF PREGNANCY | 1 0.01 3.15 ANGER | 8 0.08 3.23 ANGINA PECTORIS | 5 0.05 3.28 ANGINA UNSTABLE | 1 0.01 3.29 ANGIOEDEMA | 8 0.08 3.37 ANGIOPATHY | 1 0.01 3.38 ANGIOPLASTY | 1 0.01 3.39 ANHEDONIA | 207 2.07 5.46 ANISOCYTOSIS | 1 0.01 5.47 ANKLE FRACTURE | 3 0.03 5.50 ANOSMIA | 1 0.01 5.51 ANTINUCLEAR ANTIBODY INCREASED | 1 0.01 5.52 ANTINUCLEAR ANTIBODY POSITIVE | 1 0.01 5.53 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 2 0.02 5.55 ANTISOCIAL BEHAVIOUR | 1 0.01 5.56 ANURIA | 1 0.01 5.57 ANXIETY | 283 2.83 8.40 ANXIETY DISORDER | 2 0.02 8.42 AORTIC ANEURYSM | 1 0.01 8.43 AORTIC DISSECTION | 1 0.01 8.44 APGAR SCORE LOW | 1 0.01 8.45 APHAGIA | 2 0.02 8.47 APHASIA | 5 0.05 8.52 APHTHOUS STOMATITIS | 1 0.01 8.53 APNOEA | 1 0.01 8.54 APPENDICECTOMY | 1 0.01 8.55 APPENDICITIS | 3 0.03 8.58 APPENDICITIS PERFORATED | 1 0.01 8.59 APPENDIX DISORDER | 1 0.01 8.60 APPETITE DISORDER | 1 0.01 8.61 APPLICATION SITE ERYTHEMA | 2 0.02 8.63 APPLICATION SITE RASH | 2 0.02 8.65 APPLICATION SITE REACTION | 1 0.01 8.66 APPLICATION SITE SCAR | 1 0.01 8.67 APPLICATION SITE VESICLES | 1 0.01 8.68 APTYALISM | 1 0.01 8.69 ARRHYTHMIA | 7 0.07 8.76 ARTERIAL DISORDER | 1 0.01 8.77 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 8.78 ARTERIAL REPAIR | 1 0.01 8.79 ARTERIAL STENOSIS | 1 0.01 8.80 ARTERIAL STENT INSERTION | 1 0.01 8.81 ARTERIAL THROMBOSIS | 1 0.01 8.82 ARTERIOSCLEROSIS | 2 0.02 8.84 ARTERIOSCLEROSIS CORONARY ARTERY | 2 0.02 8.86 ARTHRALGIA | 31 0.31 9.17 ARTHRITIS | 8 0.08 9.25 ARTHRITIS INFECTIVE | 1 0.01 9.26 ARTHROPATHY | 4 0.04 9.30 ASCITES | 5 0.05 9.35 ASPARTATE AMINOTRANSFERASE INCREASED | 6 0.06 9.41 ASPIRATION | 2 0.02 9.43 ASPIRATION BONE MARROW ABNORMAL | 1 0.01 9.44 ASTHENIA | 55 0.55 9.99 ASTHENOPIA | 4 0.04 10.03 ASTHMA | 7 0.07 10.10 ATAXIA | 1 0.01 10.11 ATELECTASIS | 1 0.01 10.12 ATRIAL FIBRILLATION | 4 0.04 10.16 ATRIAL SEPTAL DEFECT | 2 0.02 10.18 ATRIOVENTRICULAR BLOCK | 1 0.01 10.19 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 10.22 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 10.23 ATRIOVENTRICULAR SEPTAL DEFECT | 1 0.01 10.24 AUTOIMMUNE THYROIDITIS | 1 0.01 10.25 AZOTAEMIA | 1 0.01 10.26 BACK DISORDER | 4 0.04 10.30 BACK INJURY | 2 0.02 10.32 BACK PAIN | 25 0.25 10.57 BACTERAEMIA | 2 0.02 10.59 BACTERIAL INFECTION | 2 0.02 10.61 BACTERIAL SEPSIS | 1 0.01 10.62 BACTERIAL TEST | 1 0.01 10.63 BALANCE DISORDER | 12 0.12 10.75 BARRETT'S OESOPHAGUS | 1 0.01 10.76 BASAL CELL CARCINOMA | 1 0.01 10.77 BEDRIDDEN | 2 0.02 10.79 BELLIGERENCE | 1 0.01 10.80 BENIGN NEOPLASM OF ADRENAL GLAND | 1 0.01 10.81 BENIGN OVARIAN TUMOUR | 1 0.01 10.82 BENIGN PANCREATIC NEOPLASM | 1 0.01 10.83 BENIGN VAGINAL NEOPLASM | 1 0.01 10.84 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 10.85 BICUSPID AORTIC VALVE | 2 0.02 10.87 BILE DUCT CANCER | 1 0.01 10.88 BILE DUCT STONE | 2 0.02 10.90 BILIARY COLIC | 2 0.02 10.92 BILIARY SEPSIS | 1 0.01 10.93 BILIRUBINURIA | 1 0.01 10.94 BINGE EATING | 1 0.01 10.95 BIOPSY | 1 0.01 10.96 BIOPSY BREAST ABNORMAL | 1 0.01 10.97 BIOPSY LYMPH GLAND | 1 0.01 10.98 BIOPSY THYMUS GLAND ABNORMAL | 1 0.01 10.99 BIPOLAR DISORDER | 4 0.04 11.03 BLADDER CATHETER REMOVAL | 1 0.01 11.04 BLADDER CATHETERISATION | 2 0.02 11.06 BLADDER DILATATION | 2 0.02 11.08 BLADDER OPERATION | 2 0.02 11.10 BLEPHAROSPASM | 1 0.01 11.11 BLIGHTED OVUM | 1 0.01 11.12 BLINDNESS | 6 0.06 11.18 BLINDNESS UNILATERAL | 1 0.01 11.19 BLISTER | 3 0.03 11.22 BLOOD ALBUMIN DECREASED | 3 0.03 11.25 BLOOD ALKALINE PHOSPHATASE INCREASED | 4 0.04 11.29 BLOOD BICARBONATE INCREASED | 1 0.01 11.30 BLOOD BILIRUBIN INCREASED | 2 0.02 11.32 BLOOD CALCIUM DECREASED | 3 0.03 11.35 BLOOD CALCIUM INCREASED | 2 0.02 11.37 BLOOD CHLORIDE DECREASED | 1 0.01 11.38 BLOOD CHLORIDE INCREASED | 1 0.01 11.39 BLOOD CHOLESTEROL INCREASED | 7 0.07 11.46 BLOOD CORTISOL ABNORMAL | 1 0.01 11.47 BLOOD CORTISOL INCREASED | 1 0.01 11.48 BLOOD COUNT ABNORMAL | 1 0.01 11.49 BLOOD CREATINE INCREASED | 2 0.02 11.51 BLOOD CREATINE PHOSPHOKINASE INCREASED | 6 0.06 11.57 BLOOD CREATININE DECREASED | 1 0.01 11.58 BLOOD CREATININE INCREASED | 5 0.05 11.63 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 11.64 BLOOD ETHANOL | 1 0.01 11.65 BLOOD FIBRINOGEN DECREASED | 1 0.01 11.66 BLOOD GLUCOSE ABNORMAL | 2 0.02 11.68 BLOOD GLUCOSE DECREASED | 3 0.03 11.71 BLOOD GLUCOSE INCREASED | 12 0.12 11.83 BLOOD HUMAN CHORIONIC GONADOTROPIN AB.. | 1 0.01 11.84 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 3 0.03 11.87 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 11.88 BLOOD INSULIN INCREASED | 1 0.01 11.89 BLOOD LACTATE DEHYDROGENASE INCREASED | 4 0.04 11.93 BLOOD LUTEINISING HORMONE DECREASED | 1 0.01 11.94 BLOOD LUTEINISING HORMONE INCREASED | 1 0.01 11.95 BLOOD MAGNESIUM DECREASED | 3 0.03 11.98 BLOOD POTASSIUM DECREASED | 2 0.02 12.00 BLOOD POTASSIUM INCREASED | 2 0.02 12.02 BLOOD PRESSURE DECREASED | 16 0.16 12.18 BLOOD PRESSURE DIASTOLIC DECREASED | 2 0.02 12.20 BLOOD PRESSURE FLUCTUATION | 7 0.07 12.27 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 12.29 BLOOD PRESSURE INCREASED | 22 0.22 12.51 BLOOD PRESSURE SYSTOLIC INCREASED | 3 0.03 12.54 BLOOD PROLACTIN INCREASED | 3 0.03 12.57 BLOOD SODIUM DECREASED | 1 0.01 12.58 BLOOD SODIUM INCREASED | 1 0.01 12.59 BLOOD TEST ABNORMAL | 3 0.03 12.62 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 12.64 BLOOD TRIGLYCERIDES INCREASED | 1 0.01 12.65 BLOOD UREA DECREASED | 1 0.01 12.66 BLOOD UREA INCREASED | 3 0.03 12.69 BLOOD UREA NITROGEN/CREATININE RATIO .. | 1 0.01 12.70 BLOOD URIC ACID INCREASED | 1 0.01 12.71 BLOOD URINE PRESENT | 3 0.03 12.74 BODY HEIGHT DECREASED | 2 0.02 12.76 BODY TEMPERATURE DECREASED | 2 0.02 12.78 BODY TEMPERATURE INCREASED | 2 0.02 12.80 BONE DEBRIDEMENT | 1 0.01 12.81 BONE DENSITY DECREASED | 1 0.01 12.82 BONE DISORDER | 7 0.07 12.89 BONE EROSION | 1 0.01 12.90 BONE FRAGMENTATION | 1 0.01 12.91 BONE MARROW FAILURE | 2 0.02 12.93 BONE MARROW TOXICITY | 1 0.01 12.94 BONE MARROW TRANSPLANT | 2 0.02 12.96 BONE NEOPLASM MALIGNANT | 1 0.01 12.97 BONE PAIN | 7 0.07 13.04 BONE SWELLING | 1 0.01 13.05 BOVINE TUBERCULOSIS | 1 0.01 13.06 BRACHIAL PLEXUS INJURY | 2 0.02 13.08 BRADYARRHYTHMIA | 1 0.01 13.09 BRADYCARDIA | 4 0.04 13.13 BRAIN NEOPLASM | 1 0.01 13.14 BREAST CANCER | 8 0.08 13.22 BREAST CANCER FEMALE | 2 0.02 13.24 BREAST CANCER IN SITU | 1 0.01 13.25 BREAST CANCER METASTATIC | 14 0.14 13.39 BREAST CANCER RECURRENT | 3 0.03 13.42 BREAST CYST | 1 0.01 13.43 BREAST DISCHARGE | 2 0.02 13.45 BREAST DISORDER | 1 0.01 13.46 BREAST MASS | 2 0.02 13.48 BREAST PAIN | 1 0.01 13.49 BREAST PROSTHESIS IMPLANTATION | 2 0.02 13.51 BREAST PROSTHESIS REMOVAL | 1 0.01 13.52 BREAST RECONSTRUCTION | 1 0.01 13.53 BREAST TENDERNESS | 1 0.01 13.54 BRONCHIAL OBSTRUCTION | 1 0.01 13.55 BRONCHITIS | 6 0.06 13.61 BRONCHOPNEUMONIA | 1 0.01 13.62 BRONCHOSPASM | 3 0.03 13.65 BRUXISM | 1 0.01 13.66 BUNDLE BRANCH BLOCK | 1 0.01 13.67 BUNDLE BRANCH BLOCK LEFT | 2 0.02 13.69 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 13.71 BURNING SENSATION | 8 0.08 13.79 BURSITIS | 4 0.04 13.83 C-REACTIVE PROTEIN DECREASED | 1 0.01 13.84 C-REACTIVE PROTEIN INCREASED | 6 0.06 13.90 CAESAREAN SECTION | 3 0.03 13.93 CALCULUS BLADDER | 1 0.01 13.94 CAMPYLOBACTER INFECTION | 1 0.01 13.95 CANDIDIASIS | 1 0.01 13.96 CAPILLARY LEAK SYNDROME | 1 0.01 13.97 CARBON DIOXIDE ABNORMAL | 1 0.01 13.98 CARBON DIOXIDE DECREASED | 1 0.01 13.99 CARBON DIOXIDE INCREASED | 1 0.01 14.00 CARDIAC ARREST | 12 0.12 14.12 CARDIAC DISORDER | 187 1.87 15.99 CARDIAC FAILURE | 18 0.18 16.17 CARDIAC FAILURE ACUTE | 1 0.01 16.18 CARDIAC FAILURE CONGESTIVE | 34 0.34 16.52 CARDIAC FLUTTER | 1 0.01 16.53 CARDIAC OPERATION | 4 0.04 16.57 CARDIAC PACEMAKER INSERTION | 3 0.03 16.60 CARDIAC VALVE DISEASE | 3 0.03 16.63 CARDIAC VENTRICULAR DISORDER | 1 0.01 16.64 CARDIO-RESPIRATORY ARREST | 10 0.10 16.74 CARDIO-RESPIRATORY DISTRESS | 1 0.01 16.75 CARDIOGENIC SHOCK | 6 0.06 16.81 CARDIOMEGALY | 4 0.04 16.85 CARDIOMYOPATHY | 3 0.03 16.88 CARDIOPULMONARY FAILURE | 1 0.01 16.89 CARDIORENAL SYNDROME | 1 0.01 16.90 CARDIOVASCULAR DISORDER | 6 0.06 16.96 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 16.97 CAROTID ARTERY OCCLUSION | 1 0.01 16.98 CARPAL TUNNEL SYNDROME | 1 0.01 16.99 CARTILAGE INJURY | 1 0.01 17.00 CATARACT | 8 0.08 17.08 CATARACT OPERATION | 2 0.02 17.10 CATATONIA | 2 0.02 17.12 CELLULITIS | 12 0.12 17.24 CELLULITIS STAPHYLOCOCCAL | 1 0.01 17.25 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 17.26 CENTRAL OBESITY | 1 0.01 17.27 CENTRAL VENOUS CATHETER REMOVAL | 1 0.01 17.28 CENTRAL VENOUS CATHETERISATION | 1 0.01 17.29 CEREBRAL ARTERIOVENOUS MALFORMATION H.. | 1 0.01 17.30 CEREBRAL ATROPHY | 1 0.01 17.31 CEREBRAL HAEMORRHAGE | 3 0.03 17.34 CEREBRAL ISCHAEMIA | 1 0.01 17.35 CEREBRAL VENOUS THROMBOSIS | 1 0.01 17.36 CEREBROVASCULAR ACCIDENT | 206 2.06 19.42 CERVICAL CORD COMPRESSION | 1 0.01 19.43 CERVICAL POLYP | 1 0.01 19.44 CERVICAL SPINAL STENOSIS | 1 0.01 19.45 CHAPPED LIPS | 2 0.02 19.47 CHEST DISCOMFORT | 10 0.10 19.57 CHEST PAIN | 34 0.34 19.91 CHILLS | 14 0.14 20.05 CHLOASMA | 1 0.01 20.06 CHOKING | 7 0.07 20.13 CHOLANGITIS | 3 0.03 20.16 CHOLANGITIS SCLEROSING | 1 0.01 20.17 CHOLECYSTECTOMY | 5 0.05 20.22 CHOLECYSTITIS | 3 0.03 20.25 CHOLECYSTITIS ACUTE | 2 0.02 20.27 CHOLECYSTITIS CHRONIC | 5 0.05 20.32 CHOLELITHIASIS | 10 0.10 20.42 CHOLESTASIS | 5 0.05 20.47 CHONDROPATHY | 1 0.01 20.48 CHROMATURIA | 6 0.06 20.54 CHRONIC FATIGUE SYNDROME | 1 0.01 20.55 CHRONIC HEPATITIS | 1 0.01 20.56 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 20.57 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 5 0.05 20.62 CIRCULATORY COLLAPSE | 4 0.04 20.66 CLAVICLE FRACTURE | 1 0.01 20.67 CLEFT LIP | 1 0.01 20.68 CLEFT LIP AND PALATE | 1 0.01 20.69 CLOSTRIDIAL INFECTION | 1 0.01 20.70 CLOSTRIDIUM DIFFICILE COLITIS | 1 0.01 20.71 CLUMSINESS | 1 0.01 20.72 COAGULATION TIME PROLONGED | 1 0.01 20.73 COAGULOPATHY | 4 0.04 20.77 COGNITIVE DISORDER | 4 0.04 20.81 COLD SWEAT | 2 0.02 20.83 COLECTOMY | 1 0.01 20.84 COLITIS | 6 0.06 20.90 COLITIS COLLAGENOUS | 1 0.01 20.91 COLITIS ISCHAEMIC | 2 0.02 20.93 COLITIS ULCERATIVE | 4 0.04 20.97 COLLAGEN DISORDER | 1 0.01 20.98 COLON CANCER | 1 0.01 20.99 COLONIC POLYP | 1 0.01 21.00 COLORECTAL CANCER | 1 0.01 21.01 COMA | 3 0.03 21.04 COMA HEPATIC | 1 0.01 21.05 COMMUNICATION DISORDER | 1 0.01 21.06 COMPLETED SUICIDE | 4 0.04 21.10 COMPLICATION OF PREGNANCY | 1 0.01 21.11 COMPUTERISED TOMOGRAM ABNORMAL | 1 0.01 21.12 CONCOMITANT DISEASE AGGRAVATED | 3 0.03 21.15 CONCUSSION | 2 0.02 21.17 CONDITION AGGRAVATED | 11 0.11 21.28 CONDUCTION DISORDER | 1 0.01 21.29 CONFUSIONAL STATE | 20 0.20 21.49 CONGENITAL ANOMALY | 2 0.02 21.51 CONGENITAL CARDIOVASCULAR ANOMALY | 1 0.01 21.52 CONGENITAL DIAPHRAGMATIC HERNIA | 1 0.01 21.53 CONGENITAL HAND MALFORMATION | 1 0.01 21.54 CONGENITAL NAEVUS | 1 0.01 21.55 CONGENITAL TRICUSPID VALVE ATRESIA | 1 0.01 21.56 CONGESTIVE CARDIOMYOPATHY | 1 0.01 21.57 CONJUNCTIVAL HYPERAEMIA | 2 0.02 21.59 CONJUNCTIVITIS | 2 0.02 21.61 CONSTIPATION | 8 0.08 21.69 CONTRALATERAL BREAST CANCER | 3 0.03 21.72 CONTUSION | 11 0.11 21.83 CONVULSION | 26 0.26 22.09 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA | 1 0.01 22.10 COORDINATION ABNORMAL | 5 0.05 22.15 CORNEAL ABRASION | 1 0.01 22.16 CORNEAL DEGENERATION | 1 0.01 22.17 CORONARY ARTERIAL STENT INSERTION | 1 0.01 22.18 CORONARY ARTERY BYPASS | 2 0.02 22.20 CORONARY ARTERY DISEASE | 11 0.11 22.31 CORONARY ARTERY OCCLUSION | 3 0.03 22.34 CORONARY ARTERY THROMBOSIS | 2 0.02 22.36 COSTOCHONDRITIS | 2 0.02 22.38 COUGH | 11 0.11 22.49 COW'S MILK INTOLERANCE | 1 0.01 22.50 CRANIOSYNOSTOSIS | 10 0.10 22.60 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 22.61 CREPITATIONS | 1 0.01 22.62 CROHN'S DISEASE | 6 0.06 22.68 CRYING | 3 0.03 22.71 CUSHINGOID | 1 0.01 22.72 CUTANEOUS VASCULITIS | 1 0.01 22.73 CYANOSIS | 2 0.02 22.75 CYST | 3 0.03 22.78 CYST REMOVAL | 1 0.01 22.79 CYSTITIS HAEMORRHAGIC | 2 0.02 22.81 CYSTITIS NONINFECTIVE | 1 0.01 22.82 CYSTOCELE | 1 0.01 22.83 CYSTOSTOMY | 1 0.01 22.84 CYTOLYTIC HEPATITIS | 5 0.05 22.89 CYTOMEGALOVIRUS ENTEROCOLITIS | 1 0.01 22.90 CYTOMEGALOVIRUS INFECTION | 3 0.03 22.93 DACRYOSTENOSIS ACQUIRED | 1 0.01 22.94 DACTYLITIS | 1 0.01 22.95 DARK CIRCLES UNDER EYES | 1 0.01 22.96 DEAFNESS | 3 0.03 22.99 DEAFNESS BILATERAL | 1 0.01 23.00 DEAFNESS UNILATERAL | 2 0.02 23.02 DEATH | 322 3.22 26.24 DEBRIDEMENT | 2 0.02 26.26 DECREASED ACTIVITY | 2 0.02 26.28 DECREASED APPETITE | 31 0.31 26.59 DECREASED INTEREST | 4 0.04 26.63 DECUBITUS ULCER | 4 0.04 26.67 DEEP VEIN THROMBOSIS | 12 0.12 26.79 DEFORMITY | 7 0.07 26.86 DEHYDRATION | 26 0.26 27.12 DELAYED SLEEP PHASE | 1 0.01 27.13 DELIRIUM | 2 0.02 27.15 DEMENTIA | 3 0.03 27.18 DEMYELINATION | 2 0.02 27.20 DENGUE FEVER | 1 0.01 27.21 DENTAL CARE | 2 0.02 27.23 DENTAL CARIES | 4 0.04 27.27 DENTAL FISTULA | 2 0.02 27.29 DENTAL IMPLANTATION | 1 0.01 27.30 DENTAL OPERATION | 1 0.01 27.31 DEPRESSED LEVEL OF CONSCIOUSNESS | 4 0.04 27.35 DEPRESSED MOOD | 11 0.11 27.46 DEPRESSION | 227 2.27 29.73 DERMATITIS | 2 0.02 29.75 DERMATITIS BULLOUS | 2 0.02 29.77 DERMATITIS CONTACT | 2 0.02 29.79 DERMATITIS EXFOLIATIVE | 3 0.03 29.82 DERMATITIS INFECTED | 1 0.01 29.83 DERMATOMYOSITIS | 1 0.01 29.84 DERMOID CYST | 1 0.01 29.85 DEVELOPMENTAL DELAY | 7 0.07 29.92 DEVICE ALARM ISSUE | 1 0.01 29.93 DEVICE BREAKAGE | 1 0.01 29.94 DEVICE DISLOCATION | 1 0.01 29.95 DEVICE EXPULSION | 1 0.01 29.96 DEVICE LEAKAGE | 2 0.02 29.98 DEVICE MALFUNCTION | 10 0.10 30.08 DIABETES INSIPIDUS | 4 0.04 30.12 DIABETES MELLITUS | 25 0.25 30.37 DIABETES MELLITUS INADEQUATE CONTROL | 6 0.06 30.43 DIABETIC COMA | 1 0.01 30.44 DIABETIC COMPLICATION | 2 0.02 30.46 DIABETIC FOOT | 2 0.02 30.48 DIABETIC GASTROPARESIS | 1 0.01 30.49 DIABETIC KETOACIDOSIS | 3 0.03 30.52 DIABETIC NEPHROPATHY | 2 0.02 30.54 DIABETIC NEUROPATHIC ULCER | 1 0.01 30.55 DIABETIC NEUROPATHY | 6 0.06 30.61 DIALYSIS | 2 0.02 30.63 DIARRHOEA | 43 0.43 31.06 DIARRHOEA HAEMORRHAGIC | 1 0.01 31.07 DIASTOLIC DYSFUNCTION | 1 0.01 31.08 DIPLOPIA | 2 0.02 31.10 DISABILITY | 1 0.01 31.11 DISCOMFORT | 3 0.03 31.14 DISEASE COMPLICATION | 1 0.01 31.15 DISEASE PROGRESSION | 6 0.06 31.21 DISEASE RECURRENCE | 1 0.01 31.22 DISINHIBITION | 1 0.01 31.23 DISORIENTATION | 7 0.07 31.30 DISSEMINATED CYTOMEGALOVIRAL INFECTION | 1 0.01 31.31 DISSEMINATED INTRAVASCULAR COAGULATION | 4 0.04 31.35 DISSOCIATION | 1 0.01 31.36 DISTURBANCE IN ATTENTION | 12 0.12 31.48 DIVERTICULITIS | 2 0.02 31.50 DIVERTICULUM | 2 0.02 31.52 DIZZINESS | 53 0.53 32.05 DIZZINESS POSTURAL | 3 0.03 32.08 DRUG ABUSE | 3 0.03 32.11 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 1 0.01 32.12 DRUG ADMINISTRATION ERROR | 2 0.02 32.14 DRUG DEPENDENCE | 3 0.03 32.17 DRUG DISPENSING ERROR | 2 0.02 32.19 DRUG DOSE OMISSION | 7 0.07 32.26 DRUG EFFECT DECREASED | 4 0.04 32.30 DRUG ERUPTION | 2 0.02 32.32 DRUG EXPOSURE DURING PREGNANCY | 50 0.50 32.82 DRUG HYPERSENSITIVITY | 5 0.05 32.87 DRUG INEFFECTIVE | 56 0.56 33.43 DRUG INTERACTION | 21 0.21 33.64 DRUG INTOLERANCE | 5 0.05 33.69 DRUG LEVEL DECREASED | 1 0.01 33.70 DRUG LEVEL INCREASED | 4 0.04 33.74 DRUG PRESCRIBING ERROR | 1 0.01 33.75 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 3 0.03 33.78 DRUG RESISTANCE | 2 0.02 33.80 DRUG SPECIFIC ANTIBODY PRESENT | 1 0.01 33.81 DRUG TOXICITY | 6 0.06 33.87 DRUG WITHDRAWAL SYNDROME | 3 0.03 33.90 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 33.91 DRY EYE | 3 0.03 33.94 DRY MOUTH | 17 0.17 34.11 DRY SKIN | 6 0.06 34.17 DRY THROAT | 1 0.01 34.18 DUODENAL ULCER HAEMORRHAGE | 2 0.02 34.20 DUODENAL ULCER PERFORATION | 1 0.01 34.21 DUPUYTREN'S CONTRACTURE | 1 0.01 34.22 DYSARTHRIA | 5 0.05 34.27 DYSGEUSIA | 5 0.05 34.32 DYSGLOBULINAEMIA | 1 0.01 34.33 DYSKINESIA | 5 0.05 34.38 DYSLALIA | 1 0.01 34.39 DYSLIPIDAEMIA | 1 0.01 34.40 DYSPAREUNIA | 1 0.01 34.41 DYSPEPSIA | 5 0.05 34.46 DYSPHAGIA | 16 0.16 34.62 DYSPHEMIA | 1 0.01 34.63 DYSPHONIA | 8 0.08 34.71 DYSPHORIA | 1 0.01 34.72 DYSPNOEA | 57 0.57 35.29 DYSPNOEA EXERTIONAL | 4 0.04 35.33 DYSSTASIA | 6 0.06 35.39 DYSTHYMIC DISORDER | 1 0.01 35.40 DYSTONIA | 3 0.03 35.43 DYSURIA | 6 0.06 35.49 EAR INFECTION | 3 0.03 35.52 EAR PAIN | 1 0.01 35.53 EATING DISORDER | 2 0.02 35.55 ECCHYMOSIS | 2 0.02 35.57 ECONOMIC PROBLEM | 1 0.01 35.58 ECZEMA | 3 0.03 35.61 EJECTION FRACTION DECREASED | 1 0.01 35.62 ELECTROCARDIOGRAM ABNORMAL | 2 0.02 35.64 ELECTROCARDIOGRAM QT PROLONGED | 5 0.05 35.69 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 35.70 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 35.71 ELECTROMECHANICAL DISSOCIATION | 1 0.01 35.72 EMBOLISM ARTERIAL | 1 0.01 35.73 EMBOLISM VENOUS | 1 0.01 35.74 EMOTIONAL DISORDER | 5 0.05 35.79 EMOTIONAL DISTRESS | 48 0.48 36.27 EMPHYSEMA | 1 0.01 36.28 ENCEPHALITIS | 2 0.02 36.30 ENCEPHALOMYELITIS | 1 0.01 36.31 ENCEPHALOPATHY | 3 0.03 36.34 ENDOCARDITIS STAPHYLOCOCCAL | 1 0.01 36.35 ENDODONTIC PROCEDURE | 1 0.01 36.36 ENDOMETRIAL DISORDER | 1 0.01 36.37 ENDOMETRIOSIS | 1 0.01 36.38 ENDOTRACHEAL INTUBATION | 1 0.01 36.39 ENTEROCOCCAL INFECTION | 1 0.01 36.40 ENTEROCOCCAL SEPSIS | 1 0.01 36.41 ENTEROCOLITIS | 1 0.01 36.42 ENTEROSTOMY | 1 0.01 36.43 EOSINOPHIL COUNT DECREASED | 1 0.01 36.44 EOSINOPHIL COUNT INCREASED | 2 0.02 36.46 EOSINOPHILIA | 3 0.03 36.49 EPHELIDES | 1 0.01 36.50 EPIDURAL ANAESTHESIA | 1 0.01 36.51 EPILEPSY | 2 0.02 36.53 EPISCLERITIS | 1 0.01 36.54 EPISTAXIS | 4 0.04 36.58 ERECTILE DYSFUNCTION | 1 0.01 36.59 EROSIVE OESOPHAGITIS | 1 0.01 36.60 ERUCTATION | 3 0.03 36.63 ERYTHEMA | 17 0.17 36.80 ERYTHEMA MULTIFORME | 3 0.03 36.83 ERYTHEMA OF EYELID | 1 0.01 36.84 ESCHERICHIA INFECTION | 1 0.01 36.85 ESCHERICHIA URINARY TRACT INFECTION | 2 0.02 36.87 EXFOLIATIVE RASH | 2 0.02 36.89 EXOPHTHALMOS | 1 0.01 36.90 EXOSTOSIS | 6 0.06 36.96 EXPIRED DRUG ADMINISTERED | 2 0.02 36.98 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 36.99 EXTRAPYRAMIDAL DISORDER | 1 0.01 37.00 EXTRASYSTOLES | 1 0.01 37.01 EXTRAVASATION | 1 0.01 37.02 EXTREMITY CONTRACTURE | 4 0.04 37.06 EXTREMITY NECROSIS | 1 0.01 37.07 EYE ABSCESS | 1 0.01 37.08 EYE DISCHARGE | 3 0.03 37.11 EYE DISORDER | 3 0.03 37.14 EYE HAEMORRHAGE | 4 0.04 37.18 EYE INFECTION | 3 0.03 37.21 EYE INFECTION VIRAL | 1 0.01 37.22 EYE MOVEMENT DISORDER | 1 0.01 37.23 EYE OEDEMA | 1 0.01 37.24 EYE OPERATION | 1 0.01 37.25 EYE PAIN | 4 0.04 37.29 EYE PRURITUS | 1 0.01 37.30 EYE SWELLING | 4 0.04 37.34 EYELID OEDEMA | 5 0.05 37.39 EYELID PTOSIS | 2 0.02 37.41 FACE INJURY | 1 0.01 37.42 FACE OEDEMA | 2 0.02 37.44 FACIAL PAIN | 1 0.01 37.45 FAECAL INCONTINENCE | 3 0.03 37.48 FAECALOMA | 1 0.01 37.49 FAECES DISCOLOURED | 3 0.03 37.52 FAECES HARD | 2 0.02 37.54 FAECES PALE | 1 0.01 37.55 FAILURE TO THRIVE | 1 0.01 37.56 FALL | 51 0.51 38.07 FAMILIAL RISK FACTOR | 1 0.01 38.08 FATIGUE | 72 0.72 38.80 FEAR | 236 2.36 41.16 FEBRILE BONE MARROW APLASIA | 1 0.01 41.17 FEBRILE CONVULSION | 7 0.07 41.24 FEBRILE NEUTROPENIA | 4 0.04 41.28 FEELING ABNORMAL | 28 0.28 41.56 FEELING COLD | 1 0.01 41.57 FEELING DRUNK | 1 0.01 41.58 FEELING GUILTY | 1 0.01 41.59 FEELING HOT | 9 0.09 41.68 FEELING JITTERY | 3 0.03 41.71 FEELING OF BODY TEMPERATURE CHANGE | 2 0.02 41.73 FEMALE STERILISATION | 1 0.01 41.74 FEMUR FRACTURE | 7 0.07 41.81 FIBROMYALGIA | 4 0.04 41.85 FIBROSIS | 3 0.03 41.88 FINGER DEFORMITY | 1 0.01 41.89 FISTULA | 2 0.02 41.91 FLANK PAIN | 1 0.01 41.92 FLATULENCE | 1 0.01 41.93 FLUID IMBALANCE | 1 0.01 41.94 FLUID OVERLOAD | 4 0.04 41.98 FLUID RETENTION | 6 0.06 42.04 FLUSHING | 5 0.05 42.09 FOETAL ANTICONVULSANT SYNDROME | 18 0.18 42.27 FOETAL CARDIAC DISORDER | 1 0.01 42.28 FOETAL HEART RATE ABNORMAL | 1 0.01 42.29 FOOT DEFORMITY | 1 0.01 42.30 FOOT FRACTURE | 2 0.02 42.32 FORMICATION | 1 0.01 42.33 FRACTURE | 2 0.02 42.35 FRACTURE NONUNION | 1 0.01 42.36 FROSTBITE | 1 0.01 42.37 FRUSTRATION | 1 0.01 42.38 FULL BLOOD COUNT ABNORMAL | 1 0.01 42.39 FULL BLOOD COUNT DECREASED | 1 0.01 42.40 FULL BLOOD COUNT INCREASED | 1 0.01 42.41 FUNGAL PERITONITIS | 5 0.05 42.46 GAIT DISTURBANCE | 32 0.32 42.78 GALLBLADDER CHOLESTEROLOSIS | 2 0.02 42.80 GALLBLADDER DISORDER | 2 0.02 42.82 GALLBLADDER ENLARGEMENT | 1 0.01 42.83 GALLBLADDER OPERATION | 1 0.01 42.84 GALLBLADDER PAIN | 1 0.01 42.85 GALLBLADDER POLYP | 2 0.02 42.87 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 1 0.01 42.88 GANGRENE | 1 0.01 42.89 GASTRECTOMY | 1 0.01 42.90 GASTRIC DISORDER | 1 0.01 42.91 GASTRIC OPERATION | 1 0.01 42.92 GASTRIC PH INCREASED | 1 0.01 42.93 GASTRIC ULCER | 2 0.02 42.95 GASTRITIS | 2 0.02 42.97 GASTRITIS EROSIVE | 1 0.01 42.98 GASTROENTERITIS | 4 0.04 43.02 GASTROENTERITIS CLOSTRIDIAL | 1 0.01 43.03 GASTROENTERITIS VIRAL | 1 0.01 43.04 GASTROINTESTINAL BACTERIAL INFECTION | 1 0.01 43.05 GASTROINTESTINAL CARCINOMA | 1 0.01 43.06 GASTROINTESTINAL DISORDER | 10 0.10 43.16 GASTROINTESTINAL HAEMORRHAGE | 9 0.09 43.25 GASTROINTESTINAL INFLAMMATION | 1 0.01 43.26 GASTROINTESTINAL NEOPLASM | 1 0.01 43.27 GASTROINTESTINAL ULCER | 1 0.01 43.28 GASTROOESOPHAGEAL REFLUX DISEASE | 12 0.12 43.40 GENERAL PHYSICAL HEALTH DETERIORATION | 18 0.18 43.58 GENERALISED ERYTHEMA | 2 0.02 43.60 GENERALISED OEDEMA | 6 0.06 43.66 GENITAL DISCOMFORT | 1 0.01 43.67 GENITAL HERPES | 1 0.01 43.68 GESTATIONAL HYPERTENSION | 2 0.02 43.70 GINGIVAL BLEEDING | 2 0.02 43.72 GINGIVAL DISORDER | 1 0.01 43.73 GINGIVAL HYPERPLASIA | 4 0.04 43.77 GINGIVAL PAIN | 1 0.01 43.78 GINGIVAL RECESSION | 2 0.02 43.80 GINGIVAL SWELLING | 1 0.01 43.81 GINGIVITIS | 5 0.05 43.86 GLAUCOMA | 2 0.02 43.88 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 43.89 GLOMERULONEPHRITIS | 2 0.02 43.91 GLOMERULONEPHRITIS MINIMAL LESION | 1 0.01 43.92 GLOMERULOSCLEROSIS | 1 0.01 43.93 GLOSSODYNIA | 2 0.02 43.95 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 43.96 GLYCOSURIA | 1 0.01 43.97 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 43.98 GOITRE | 1 0.01 43.99 GOUT | 3 0.03 44.02 GRAFT COMPLICATION | 3 0.03 44.05 GRAND MAL CONVULSION | 2 0.02 44.07 GRANULOCYTOPENIA | 1 0.01 44.08 GRANULOMA | 2 0.02 44.10 GROIN PAIN | 2 0.02 44.12 GUILLAIN-BARRE SYNDROME | 3 0.03 44.15 GYNAECOMASTIA | 1 0.01 44.16 H1N1 INFLUENZA | 2 0.02 44.18 HAEMATEMESIS | 3 0.03 44.21 HAEMATOCHEZIA | 5 0.05 44.26 HAEMATOCRIT DECREASED | 6 0.06 44.32 HAEMATOMA | 1 0.01 44.33 HAEMATOTOXICITY | 1 0.01 44.34 HAEMATURIA | 14 0.14 44.48 HAEMOCHROMATOSIS | 1 0.01 44.49 HAEMODIALYSIS | 2 0.02 44.51 HAEMODYNAMIC INSTABILITY | 3 0.03 44.54 HAEMOGLOBIN DECREASED | 11 0.11 44.65 HAEMOGLOBIN INCREASED | 1 0.01 44.66 HAEMOLYSIS | 2 0.02 44.68 HAEMOPTYSIS | 2 0.02 44.70 HAEMORRHAGE | 11 0.11 44.81 HAEMORRHAGE INTRACRANIAL | 1 0.01 44.82 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 44.83 HAEMORRHAGIC OVARIAN CYST | 1 0.01 44.84 HAEMORRHAGIC STROKE | 1 0.01 44.85 HAEMORRHOIDS | 3 0.03 44.88 HALLUCINATION | 11 0.11 44.99 HALLUCINATION, AUDITORY | 3 0.03 45.02 HALLUCINATION, VISUAL | 2 0.02 45.04 HAND FRACTURE | 1 0.01 45.05 HAND-FOOT-AND-MOUTH DISEASE | 1 0.01 45.06 HEAD DISCOMFORT | 2 0.02 45.08 HEAD INJURY | 5 0.05 45.13 HEADACHE | 43 0.43 45.56 HEARING IMPAIRED | 1 0.01 45.57 HEART RATE ABNORMAL | 1 0.01 45.58 HEART RATE DECREASED | 3 0.03 45.61 HEART RATE INCREASED | 15 0.15 45.76 HEART RATE IRREGULAR | 2 0.02 45.78 HEART VALVE REPLACEMENT | 1 0.01 45.79 HELICOBACTER GASTRITIS | 1 0.01 45.80 HELLP SYNDROME | 1 0.01 45.81 HEMIPARESIS | 1 0.01 45.82 HEMIPLEGIA | 1 0.01 45.83 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 45.84 HEPATIC CIRRHOSIS | 4 0.04 45.88 HEPATIC CONGESTION | 1 0.01 45.89 HEPATIC CYST | 1 0.01 45.90 HEPATIC ENCEPHALOPATHY | 3 0.03 45.93 HEPATIC ENZYME INCREASED | 7 0.07 46.00 HEPATIC FAILURE | 2 0.02 46.02 HEPATIC FUNCTION ABNORMAL | 10 0.10 46.12 HEPATIC LESION | 3 0.03 46.15 HEPATIC NEOPLASM | 1 0.01 46.16 HEPATIC NEOPLASM MALIGNANT | 1 0.01 46.17 HEPATIC STEATOSIS | 6 0.06 46.23 HEPATITIS | 4 0.04 46.27 HEPATITIS A | 1 0.01 46.28 HEPATITIS B | 1 0.01 46.29 HEPATITIS C | 3 0.03 46.32 HEPATITIS CHOLESTATIC | 4 0.04 46.36 HEPATITIS TOXIC | 1 0.01 46.37 HEPATOMEGALY | 4 0.04 46.41 HERNIA | 2 0.02 46.43 HERPES SIMPLEX | 1 0.01 46.44 HERPES VIRUS INFECTION | 1 0.01 46.45 HERPES ZOSTER | 13 0.13 46.58 HERPES ZOSTER DISSEMINATED | 1 0.01 46.59 HIGH RISK PREGNANCY | 3 0.03 46.62 HIP ARTHROPLASTY | 3 0.03 46.65 HIP FRACTURE | 5 0.05 46.70 HISTAMINE LEVEL INCREASED | 1 0.01 46.71 HISTIOCYTIC NECROTISING LYMPHADENITIS | 1 0.01 46.72 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 46.73 HISTOPLASMOSIS | 1 0.01 46.74 HISTOPLASMOSIS DISSEMINATED | 1 0.01 46.75 HODGKIN'S DISEASE | 2 0.02 46.77 HOMICIDAL IDEATION | 2 0.02 46.79 HORDEOLUM | 1 0.01 46.80 HOSPITALISATION | 7 0.07 46.87 HOSTILITY | 2 0.02 46.89 HOT FLUSH | 1 0.01 46.90 HUMAN PAPILLOMA VIRUS TEST POSITIVE | 1 0.01 46.91 HUNGER | 1 0.01 46.92 HYDROCEPHALUS | 1 0.01 46.93 HYDRONEPHROSIS | 2 0.02 46.95 HYPERAESTHESIA | 2 0.02 46.97 HYPERAMMONAEMIA | 1 0.01 46.98 HYPERBARIC OXYGEN THERAPY | 1 0.01 46.99 HYPERBILIRUBINAEMIA | 3 0.03 47.02 HYPERCALCAEMIA | 3 0.03 47.05 HYPERCHOLESTEROLAEMIA | 3 0.03 47.08 HYPERGLYCAEMIA | 10 0.10 47.18 HYPERHIDROSIS | 23 0.23 47.41 HYPERKALAEMIA | 3 0.03 47.44 HYPERKERATOSIS | 2 0.02 47.46 HYPERKINESIA | 1 0.01 47.47 HYPERLIPIDAEMIA | 5 0.05 47.52 HYPERPROLACTINAEMIA | 1 0.01 47.53 HYPERSENSITIVITY | 22 0.22 47.75 HYPERSOMNIA | 8 0.08 47.83 HYPERSPLENISM | 1 0.01 47.84 HYPERTENSION | 30 0.30 48.14 HYPERTENSIVE CARDIOMYOPATHY | 1 0.01 48.15 HYPERTENSIVE CRISIS | 3 0.03 48.18 HYPERTENSIVE EMERGENCY | 1 0.01 48.19 HYPERTENSIVE HEART DISEASE | 1 0.01 48.20 HYPERTHERMIA | 2 0.02 48.22 HYPERTHYROIDISM | 2 0.02 48.24 HYPERTONIA | 2 0.02 48.26 HYPERTONIC BLADDER | 1 0.01 48.27 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 48.28 HYPERURICAEMIA | 1 0.01 48.29 HYPOACUSIS | 4 0.04 48.33 HYPOAESTHESIA | 25 0.25 48.58 HYPOAESTHESIA ORAL | 3 0.03 48.61 HYPOALBUMINAEMIA | 3 0.03 48.64 HYPOCHROMIC ANAEMIA | 1 0.01 48.65 HYPOGAMMAGLOBULINAEMIA | 2 0.02 48.67 HYPOGLYCAEMIA | 11 0.11 48.78 HYPOGLYCAEMIC COMA | 1 0.01 48.79 HYPOGLYCAEMIC UNCONSCIOUSNESS | 1 0.01 48.80 HYPOKALAEMIA | 2 0.02 48.82 HYPOKINESIA | 1 0.01 48.83 HYPOMANIA | 1 0.01 48.84 HYPONATRAEMIA | 9 0.09 48.93 HYPOPHAGIA | 2 0.02 48.95 HYPOREFLEXIA | 1 0.01 48.96 HYPOSPADIAS | 2 0.02 48.98 HYPOTENSION | 30 0.30 49.28 HYPOTHERMIA | 2 0.02 49.30 HYPOTHYROIDISM | 2 0.02 49.32 HYPOVENTILATION | 1 0.01 49.33 HYPOVOLAEMIA | 2 0.02 49.35 HYPOXIA | 4 0.04 49.39 HYSTERECTOMY | 2 0.02 49.41 HYSTEROTOMY | 1 0.01 49.42 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 49.43 IGA NEPHROPATHY | 1 0.01 49.44 ILEUS | 6 0.06 49.50 ILEUS PARALYTIC | 1 0.01 49.51 ILL-DEFINED DISORDER | 2 0.02 49.53 IMMUNE RECONSTITUTION SYNDROME | 2 0.02 49.55 IMMUNODEFICIENCY | 2 0.02 49.57 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED | 1 0.01 49.58 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 49.59 IMMUNOSUPPRESSION | 2 0.02 49.61 IMPAIRED DRIVING ABILITY | 1 0.01 49.62 IMPAIRED GASTRIC EMPTYING | 1 0.01 49.63 IMPAIRED HEALING | 6 0.06 49.69 IMPAIRED WORK ABILITY | 2 0.02 49.71 IMPETIGO | 1 0.01 49.72 IMPLANT SITE NECROSIS | 1 0.01 49.73 IMPLANTABLE DEFIBRILLATOR INSERTION | 2 0.02 49.75 IMPULSIVE BEHAVIOUR | 1 0.01 49.76 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 1 0.01 49.77 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 3 0.03 49.80 INCISION SITE PAIN | 2 0.02 49.82 INCISION SITE PRURITUS | 1 0.01 49.83 INCONTINENCE | 2 0.02 49.85 INCORRECT DOSE ADMINISTERED | 2 0.02 49.87 INCORRECT DRUG ADMINISTRATION RATE | 1 0.01 49.88 INCORRECT ROUTE OF DRUG ADMINISTRATION | 1 0.01 49.89 INCORRECT STORAGE OF DRUG | 3 0.03 49.92 INCREASED APPETITE | 1 0.01 49.93 INCREASED TENDENCY TO BRUISE | 1 0.01 49.94 INCREASED UPPER AIRWAY SECRETION | 2 0.02 49.96 INDIFFERENCE | 1 0.01 49.97 INDURATION | 1 0.01 49.98 INFARCTION | 2 0.02 50.00 INFECTION | 10 0.10 50.10 INFECTIOUS MONONUCLEOSIS | 1 0.01 50.11 INFECTIVE THROMBOSIS | 1 0.01 50.12 INFERTILITY FEMALE | 2 0.02 50.14 INFLAMMATION | 9 0.09 50.23 INFLAMMATORY BOWEL DISEASE | 4 0.04 50.27 INFLUENZA | 6 0.06 50.33 INFLUENZA LIKE ILLNESS | 15 0.15 50.48 INFUSION RELATED REACTION | 6 0.06 50.54 INFUSION SITE EXTRAVASATION | 1 0.01 50.55 INFUSION SITE PAIN | 1 0.01 50.56 INFUSION SITE ULCER | 1 0.01 50.57 INJECTION SITE ABSCESS | 1 0.01 50.58 INJECTION SITE ERYTHEMA | 2 0.02 50.60 INJECTION SITE EXTRAVASATION | 1 0.01 50.61 INJECTION SITE HAEMATOMA | 1 0.01 50.62 INJECTION SITE HAEMORRHAGE | 6 0.06 50.68 INJECTION SITE MASS | 1 0.01 50.69 INJECTION SITE PAIN | 7 0.07 50.76 INJECTION SITE REACTION | 2 0.02 50.78 INJECTION SITE SWELLING | 1 0.01 50.79 INJURY | 279 2.79 53.58 INSOMNIA | 28 0.28 53.86 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 1 0.01 53.87 INTENTIONAL DRUG MISUSE | 4 0.04 53.91 INTENTIONAL OVERDOSE | 1 0.01 53.92 INTERNAL FIXATION OF FRACTURE | 1 0.01 53.93 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 53.94 INTERNATIONAL NORMALISED RATIO INCREA.. | 2 0.02 53.96 INTERSTITIAL LUNG DISEASE | 10 0.10 54.06 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 54.07 INTERVERTEBRAL DISC DISORDER | 1 0.01 54.08 INTERVERTEBRAL DISC PROTRUSION | 9 0.09 54.17 INTESTINAL ANASTOMOSIS COMPLICATION | 1 0.01 54.18 INTESTINAL FISTULA | 1 0.01 54.19 INTESTINAL HAEMORRHAGE | 2 0.02 54.21 INTESTINAL ISCHAEMIA | 1 0.01 54.22 INTESTINAL OBSTRUCTION | 4 0.04 54.26 INTESTINAL OPERATION | 2 0.02 54.28 INTESTINAL PERFORATION | 3 0.03 54.31 INTESTINAL POLYP | 1 0.01 54.32 INTESTINAL RESECTION | 2 0.02 54.34 INTESTINAL STENOSIS | 1 0.01 54.35 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 54.36 INTRA-UTERINE DEATH | 3 0.03 54.39 INTRACARDIAC THROMBUS | 1 0.01 54.40 INTRAOCULAR PRESSURE INCREASED | 7 0.07 54.47 IRON DEFICIENCY | 1 0.01 54.48 IRRITABILITY | 9 0.09 54.57 IRRITABLE BOWEL SYNDROME | 1 0.01 54.58 ISCHAEMIA | 1 0.01 54.59 ISCHAEMIC STROKE | 3 0.03 54.62 JAUNDICE | 6 0.06 54.68 JAUNDICE CHOLESTATIC | 1 0.01 54.69 JAW DISORDER | 3 0.03 54.72 JAW OPERATION | 1 0.01 54.73 JOINT CONTRACTURE | 3 0.03 54.76 JOINT DISLOCATION | 3 0.03 54.79 JOINT EFFUSION | 2 0.02 54.81 JOINT INJURY | 2 0.02 54.83 JOINT LOCK | 2 0.02 54.85 JOINT RANGE OF MOTION DECREASED | 2 0.02 54.87 JOINT SPRAIN | 2 0.02 54.89 JOINT STIFFNESS | 6 0.06 54.95 JOINT SURGERY | 1 0.01 54.96 JOINT SWELLING | 12 0.12 55.08 JOINT TUBERCULOSIS | 1 0.01 55.09 JUGULAR VEIN THROMBOSIS | 1 0.01 55.10 KELOID SCAR | 1 0.01 55.11 KERATOCONJUNCTIVITIS SICCA | 1 0.01 55.12 KIDNEY INFECTION | 2 0.02 55.14 KIDNEY MALFORMATION | 1 0.01 55.15 KIDNEY MALROTATION | 1 0.01 55.16 KIDNEY TRANSPLANT REJECTION | 1 0.01 55.17 KNEE ARTHROPLASTY | 3 0.03 55.20 KNEE OPERATION | 2 0.02 55.22 LABILE BLOOD PRESSURE | 1 0.01 55.23 LABORATORY TEST ABNORMAL | 3 0.03 55.26 LACERATION | 1 0.01 55.27 LACRIMATION INCREASED | 4 0.04 55.31 LACTIC ACIDOSIS | 1 0.01 55.32 LARGE FOR DATES BABY | 1 0.01 55.33 LARGE INTESTINAL ULCER | 2 0.02 55.35 LARGE INTESTINE CARCINOMA | 1 0.01 55.36 LARGE INTESTINE OPERATION | 1 0.01 55.37 LARGE INTESTINE PERFORATION | 1 0.01 55.38 LARYNGEAL OEDEMA | 2 0.02 55.40 LARYNGOCELE | 1 0.01 55.41 LARYNGOMALACIA | 1 0.01 55.42 LARYNGOSPASM | 1 0.01 55.43 LARYNX IRRITATION | 1 0.01 55.44 LEFT ATRIAL DILATATION | 1 0.01 55.45 LEFT VENTRICULAR DYSFUNCTION | 2 0.02 55.47 LEFT VENTRICULAR FAILURE | 2 0.02 55.49 LETHARGY | 8 0.08 55.57 LEUKAEMIA | 1 0.01 55.58 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 55.59 LEUKOCYTURIA | 1 0.01 55.60 LEUKOENCEPHALOPATHY | 1 0.01 55.61 LEUKOPENIA | 5 0.05 55.66 LIBIDO INCREASED | 1 0.01 55.67 LICHEN PLANUS | 1 0.01 55.68 LICHENIFICATION | 1 0.01 55.69 LIGAMENT RUPTURE | 1 0.01 55.70 LIMB DISCOMFORT | 1 0.01 55.71 LIMB HYPOPLASIA CONGENITAL | 1 0.01 55.72 LIMB INJURY | 5 0.05 55.77 LIP AND/OR ORAL CAVITY CANCER STAGE IV | 1 0.01 55.78 LIP BLISTER | 1 0.01 55.79 LIP DISCOLOURATION | 1 0.01 55.80 LIP DRY | 1 0.01 55.81 LIP OEDEMA | 5 0.05 55.86 LIP SWELLING | 10 0.10 55.96 LIPIDS ABNORMAL | 1 0.01 55.97 LIPIDS INCREASED | 1 0.01 55.98 LIPODYSTROPHY ACQUIRED | 1 0.01 55.99 LIPOMA | 1 0.01 56.00 LISTLESS | 1 0.01 56.01 LIVEDO RETICULARIS | 2 0.02 56.03 LIVER ABSCESS | 1 0.01 56.04 LIVER DISORDER | 7 0.07 56.11 LIVER FUNCTION TEST ABNORMAL | 9 0.09 56.20 LOCALISED OEDEMA | 1 0.01 56.21 LOOSE TOOTH | 4 0.04 56.25 LOSS OF CONSCIOUSNESS | 16 0.16 56.41 LOSS OF CONTROL OF LEGS | 1 0.01 56.42 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 56.43 LOWER EXTREMITY MASS | 1 0.01 56.44 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 56.45 LOWER LIMB FRACTURE | 2 0.02 56.47 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 56.48 LUNG CANCER METASTATIC | 1 0.01 56.49 LUNG DISORDER | 3 0.03 56.52 LUNG INFECTION | 2 0.02 56.54 LUNG INFILTRATION | 2 0.02 56.56 LUNG NEOPLASM MALIGNANT | 8 0.08 56.64 LUNG SQUAMOUS CELL CARCINOMA STAGE I | 1 0.01 56.65 LUPUS-LIKE SYNDROME | 1 0.01 56.66 LYMPHADENECTOMY | 2 0.02 56.68 LYMPHADENITIS | 1 0.01 56.69 LYMPHADENOPATHY | 8 0.08 56.77 LYMPHANGIOSIS CARCINOMATOSA | 1 0.01 56.78 LYMPHOCELE | 1 0.01 56.79 LYMPHOCYTE COUNT DECREASED | 1 0.01 56.80 LYMPHOCYTOSIS | 1 0.01 56.81 LYMPHOEDEMA | 2 0.02 56.83 LYMPHOMA | 2 0.02 56.85 LYMPHOPENIA | 5 0.05 56.90 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 56.91 MACROCYTOSIS | 2 0.02 56.93 MACROGLOSSIA | 1 0.01 56.94 MACULAR DEGENERATION | 2 0.02 56.96 MAJOR DEPRESSION | 1 0.01 56.97 MALAISE | 48 0.48 57.45 MALIGNANT MELANOMA | 1 0.01 57.46 MALIGNANT NEOPLASM PROGRESSION | 6 0.06 57.52 MALNUTRITION | 2 0.02 57.54 MAMMOPLASTY | 1 0.01 57.55 MANIA | 4 0.04 57.59 MARROW HYPERPLASIA | 1 0.01 57.60 MASKED FACIES | 2 0.02 57.62 MASS | 2 0.02 57.64 MASS EXCISION | 1 0.01 57.65 MASTECTOMY | 1 0.01 57.66 MASTICATION DISORDER | 1 0.01 57.67 MEAN CELL HAEMOGLOBIN DECREASED | 1 0.01 57.68 MEAN CELL VOLUME DECREASED | 1 0.01 57.69 MEAN CELL VOLUME INCREASED | 1 0.01 57.70 MECHANICAL VENTILATION | 3 0.03 57.73 MEDICAL DEVICE COMPLICATION | 1 0.01 57.74 MEDICAL DEVICE REMOVAL | 1 0.01 57.75 MEDICATION ERROR | 1 0.01 57.76 MEDICATION RESIDUE | 1 0.01 57.77 MEGACOLON | 1 0.01 57.78 MELAENA | 4 0.04 57.82 MELANOCYTIC NAEVUS | 1 0.01 57.83 MEMORY IMPAIRMENT | 21 0.21 58.04 MENINGITIS | 1 0.01 58.05 MENISCUS LESION | 4 0.04 58.09 MENOPAUSE | 1 0.01 58.10 MENSTRUATION DELAYED | 2 0.02 58.12 MENSTRUATION IRREGULAR | 1 0.01 58.13 MENTAL DISORDER | 9 0.09 58.22 MENTAL IMPAIRMENT | 5 0.05 58.27 MENTAL STATUS CHANGES | 8 0.08 58.35 METABOLIC ACIDOSIS | 1 0.01 58.36 METABOLIC ENCEPHALOPATHY | 1 0.01 58.37 METASTASES TO BONE | 3 0.03 58.40 METASTASES TO BONE MARROW | 1 0.01 58.41 METASTASES TO CENTRAL NERVOUS SYSTEM | 2 0.02 58.43 METASTASES TO KIDNEY | 1 0.01 58.44 METASTASES TO LIVER | 3 0.03 58.47 METASTASES TO LUNG | 1 0.01 58.48 METASTASES TO LYMPH NODES | 3 0.03 58.51 METASTATIC CARCINOID TUMOUR | 1 0.01 58.52 METASTATIC NEOPLASM | 4 0.04 58.56 METASTATIC PAIN | 1 0.01 58.57 METASTATIC RENAL CELL CARCINOMA | 1 0.01 58.58 METRORRHAGIA | 3 0.03 58.61 MICROALBUMINURIA | 1 0.01 58.62 MIDDLE INSOMNIA | 1 0.01 58.63 MIGRAINE | 10 0.10 58.73 MIGRAINE WITH AURA | 2 0.02 58.75 MILIA | 1 0.01 58.76 MIOSIS | 1 0.01 58.77 MITRAL VALVE CALCIFICATION | 1 0.01 58.78 MITRAL VALVE INCOMPETENCE | 2 0.02 58.80 MIXED SALIVARY TUMOUR | 1 0.01 58.81 MOBILITY DECREASED | 15 0.15 58.96 MONOCYTE COUNT INCREASED | 1 0.01 58.97 MONOCYTOSIS | 1 0.01 58.98 MONOPLEGIA | 1 0.01 58.99 MOOD ALTERED | 3 0.03 59.02 MOOD SWINGS | 3 0.03 59.05 MOTOR DEVELOPMENTAL DELAY | 2 0.02 59.07 MOTOR DYSFUNCTION | 2 0.02 59.09 MOUTH BREATHING | 1 0.01 59.10 MOUTH HAEMORRHAGE | 2 0.02 59.12 MOUTH INJURY | 2 0.02 59.14 MOUTH ULCERATION | 6 0.06 59.20 MOVEMENT DISORDER | 3 0.03 59.23 MUCOSAL HAEMORRHAGE | 1 0.01 59.24 MUCOSAL INFLAMMATION | 1 0.01 59.25 MUCOUS MEMBRANE DISORDER | 1 0.01 59.26 MULTI-ORGAN DISORDER | 2 0.02 59.28 MULTI-ORGAN FAILURE | 56 0.56 59.84 MULTIPLE DRUG OVERDOSE | 1 0.01 59.85 MULTIPLE DRUG OVERDOSE INTENTIONAL | 1 0.01 59.86 MULTIPLE INJURIES | 1 0.01 59.87 MULTIPLE MYELOMA | 9 0.09 59.96 MULTIPLE SCLEROSIS | 6 0.06 60.02 MULTIPLE SCLEROSIS RELAPSE | 18 0.18 60.20 MUSCLE ATROPHY | 1 0.01 60.21 MUSCLE CONTRACTIONS INVOLUNTARY | 2 0.02 60.23 MUSCLE CONTRACTURE | 1 0.01 60.24 MUSCLE DISORDER | 1 0.01 60.25 MUSCLE HAEMORRHAGE | 1 0.01 60.26 MUSCLE RIGIDITY | 2 0.02 60.28 MUSCLE RUPTURE | 2 0.02 60.30 MUSCLE SPASMS | 22 0.22 60.52 MUSCLE SPASTICITY | 6 0.06 60.58 MUSCLE TIGHTNESS | 2 0.02 60.60 MUSCLE TWITCHING | 2 0.02 60.62 MUSCULAR WEAKNESS | 24 0.24 60.86 MUSCULOSKELETAL CHEST PAIN | 3 0.03 60.89 MUSCULOSKELETAL DISCOMFORT | 3 0.03 60.92 MUSCULOSKELETAL DISORDER | 4 0.04 60.96 MUSCULOSKELETAL PAIN | 6 0.06 61.02 MUSCULOSKELETAL STIFFNESS | 13 0.13 61.15 MYALGIA | 18 0.18 61.33 MYASTHENIA GRAVIS | 1 0.01 61.34 MYCOPLASMA TEST POSITIVE | 1 0.01 61.35 MYDRIASIS | 2 0.02 61.37 MYELODYSPLASTIC SYNDROME | 2 0.02 61.39 MYELODYSPLASTIC SYNDROME TRANSFORMATION | 2 0.02 61.41 MYOCARDIAL INFARCTION | 70 0.70 62.11 MYOCARDIAL ISCHAEMIA | 3 0.03 62.14 MYOCLONUS | 1 0.01 62.15 MYOGLOBINURIA | 1 0.01 62.16 MYOPATHY | 3 0.03 62.19 MYOSCLEROSIS | 1 0.01 62.20 MYOSITIS | 2 0.02 62.22 NAIL BED BLEEDING | 1 0.01 62.23 NAIL DISORDER | 1 0.01 62.24 NARCOLEPSY | 1 0.01 62.25 NARCOTIC INTOXICATION | 1 0.01 62.26 NASAL CONGESTION | 3 0.03 62.29 NASAL DISCOMFORT | 1 0.01 62.30 NASAL DISORDER | 1 0.01 62.31 NASAL POLYPS | 1 0.01 62.32 NASAL SEPTUM PERFORATION | 1 0.01 62.33 NASAL ULCER | 1 0.01 62.34 NASOPHARYNGITIS | 9 0.09 62.43 NAUSEA | 67 0.67 63.10 NECK PAIN | 13 0.13 63.23 NECROSIS | 1 0.01 63.24 NEGATIVE THOUGHTS | 1 0.01 63.25 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 63.26 NEOPLASM MALIGNANT | 3 0.03 63.29 NEOPLASM PROGRESSION | 4 0.04 63.33 NEOPLASM PROSTATE | 1 0.01 63.34 NEOPLASM RECURRENCE | 2 0.02 63.36 NEPHRECTOMY | 1 0.01 63.37 NEPHRITIS | 1 0.01 63.38 NEPHROGENIC SYSTEMIC FIBROSIS | 8 0.08 63.46 NEPHROLITHIASIS | 8 0.08 63.54 NEPHROPATHY | 2 0.02 63.56 NEPHROTIC SYNDROME | 2 0.02 63.58 NERVE COMPRESSION | 1 0.01 63.59 NERVE INJURY | 1 0.01 63.60 NERVOUS SYSTEM DISORDER | 5 0.05 63.65 NERVOUSNESS | 17 0.17 63.82 NEURALGIA | 3 0.03 63.85 NEUROLEPTIC MALIGNANT SYNDROME | 1 0.01 63.86 NEUROLOGICAL EXAMINATION ABNORMAL | 2 0.02 63.88 NEUROLOGICAL SYMPTOM | 3 0.03 63.91 NEUROMUSCULAR BLOCKADE | 1 0.01 63.92 NEUROPATHY PERIPHERAL | 16 0.16 64.08 NEUROSIS | 1 0.01 64.09 NEUROTOXICITY | 3 0.03 64.12 NEUTROPENIA | 11 0.11 64.23 NEUTROPENIC SEPSIS | 2 0.02 64.25 NEUTROPHIL COUNT DECREASED | 2 0.02 64.27 NEUTROPHIL COUNT INCREASED | 3 0.03 64.30 NEUTROPHIL MORPHOLOGY ABNORMAL | 1 0.01 64.31 NIGHT SWEATS | 3 0.03 64.34 NIGHTMARE | 4 0.04 64.38 NOCTURIA | 2 0.02 64.40 NON-CARDIAC CHEST PAIN | 1 0.01 64.41 NON-HODGKIN'S LYMPHOMA RECURRENT | 1 0.01 64.42 NON-HODGKIN'S LYMPHOMA STAGE IV | 1 0.01 64.43 NON-SMALL CELL LUNG CANCER STAGE IV | 1 0.01 64.44 NONSPECIFIC REACTION | 1 0.01 64.45 NORMAL NEWBORN | 3 0.03 64.48 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 64.49 NYSTAGMUS | 1 0.01 64.50 OBESITY | 4 0.04 64.54 OBSESSIVE THOUGHTS | 1 0.01 64.55 OCCULT BLOOD POSITIVE | 1 0.01 64.56 OCCUPATIONAL EXPOSURE TO DRUG | 1 0.01 64.57 OCULAR HYPERAEMIA | 2 0.02 64.59 OCULAR ICTERUS | 2 0.02 64.61 OCULAR VASCULAR DISORDER | 1 0.01 64.62 ODYNOPHAGIA | 2 0.02 64.64 OEDEMA | 9 0.09 64.73 OEDEMA PERIPHERAL | 39 0.39 65.12 OESOPHAGEAL CARCINOMA | 2 0.02 65.14 OESOPHAGEAL PAIN | 1 0.01 65.15 OESOPHAGEAL SPASM | 1 0.01 65.16 OESTRADIOL INCREASED | 1 0.01 65.17 OFF LABEL USE | 12 0.12 65.29 OLIGOHYDRAMNIOS | 1 0.01 65.30 OLIGURIA | 5 0.05 65.35 OMENTECTOMY | 1 0.01 65.36 ONYCHOLYSIS | 1 0.01 65.37 ONYCHOMYCOSIS | 1 0.01 65.38 OPEN WOUND | 1 0.01 65.39 OPPORTUNISTIC INFECTION | 1 0.01 65.40 OPTIC NERVE DISORDER | 1 0.01 65.41 OPTIC NERVE INJURY | 1 0.01 65.42 OPTIC NEURITIS | 1 0.01 65.43 ORAL DISCOMFORT | 1 0.01 65.44 ORAL DISORDER | 2 0.02 65.46 ORAL FUNGAL INFECTION | 1 0.01 65.47 ORAL HERPES | 3 0.03 65.50 ORAL INFECTION | 1 0.01 65.51 ORAL PAIN | 1 0.01 65.52 ORGAN FAILURE | 170 1.70 67.22 OROMANDIBULAR DYSTONIA | 1 0.01 67.23 OROPHARYNGEAL BLISTERING | 2 0.02 67.25 OROPHARYNGEAL DISCOMFORT | 1 0.01 67.26 OROPHARYNGEAL PAIN | 5 0.05 67.31 OROPHARYNGITIS FUNGAL | 1 0.01 67.32 ORTHOPEDIC PROCEDURE | 1 0.01 67.33 ORTHOSTATIC HYPOTENSION | 2 0.02 67.35 OSTEITIS | 2 0.02 67.37 OSTEOARTHRITIS | 4 0.04 67.41 OSTEOLYSIS | 1 0.01 67.42 OSTEOMYELITIS | 5 0.05 67.47 OSTEONECROSIS | 2 0.02 67.49 OSTEONECROSIS OF JAW | 10 0.10 67.59 OSTEOPENIA | 2 0.02 67.61 OSTEOPOROSIS | 7 0.07 67.68 OSTEOPOROTIC FRACTURE | 1 0.01 67.69 OSTEORADIONECROSIS | 1 0.01 67.70 OVARIAN CANCER | 1 0.01 67.71 OVARIAN CANCER METASTATIC | 1 0.01 67.72 OVARIAN CYST | 1 0.01 67.73 OVARIAN CYST RUPTURED | 1 0.01 67.74 OVARIAN EPITHELIAL CANCER | 1 0.01 67.75 OVERDOSE | 22 0.22 67.97 OVERWORK | 1 0.01 67.98 OXYGEN SATURATION DECREASED | 3 0.03 68.01 PAIN | 332 3.32 71.33 PAIN IN EXTREMITY | 24 0.24 71.57 PAIN IN JAW | 3 0.03 71.60 PAIN OF SKIN | 3 0.03 71.63 PALATAL OEDEMA | 1 0.01 71.64 PALLOR | 3 0.03 71.67 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 3 0.03 71.70 PALPITATIONS | 12 0.12 71.82 PANCREATIC DISORDER | 2 0.02 71.84 PANCREATIC INSUFFICIENCY | 1 0.01 71.85 PANCREATITIS | 14 0.14 71.99 PANCREATITIS ACUTE | 6 0.06 72.05 PANCREATITIS CHRONIC | 1 0.01 72.06 PANCYTOPENIA | 7 0.07 72.13 PANIC ATTACK | 2 0.02 72.15 PANIC DISORDER | 1 0.01 72.16 PANIC REACTION | 2 0.02 72.18 PARAESTHESIA | 20 0.20 72.38 PARAESTHESIA ORAL | 3 0.03 72.41 PARALYSIS | 3 0.03 72.44 PARANOIA | 3 0.03 72.47 PARAPROTEINAEMIA | 1 0.01 72.48 PARATHYROID TUMOUR BENIGN | 1 0.01 72.49 PARESIS | 1 0.01 72.50 PARKINSON'S DISEASE | 4 0.04 72.54 PARKINSONISM | 2 0.02 72.56 PARONYCHIA | 1 0.01 72.57 PAROSMIA | 1 0.01 72.58 PATELLA FRACTURE | 1 0.01 72.59 PATHOLOGICAL FRACTURE | 1 0.01 72.60 PEAU D'ORANGE | 1 0.01 72.61 PELVIC ADHESIONS | 1 0.01 72.62 PEMPHIGOID | 1 0.01 72.63 PEMPHIGUS | 1 0.01 72.64 PENILE OEDEMA | 1 0.01 72.65 PENILE VASCULAR DISORDER | 1 0.01 72.66 PERIARTHRITIS | 1 0.01 72.67 PERICARDIAL EFFUSION | 4 0.04 72.71 PERICARDIAL HAEMORRHAGE | 1 0.01 72.72 PERICARDITIS INFECTIVE | 1 0.01 72.73 PERIODONTAL DISEASE | 1 0.01 72.74 PERIORBITAL HAEMATOMA | 1 0.01 72.75 PERIORBITAL OEDEMA | 1 0.01 72.76 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 2 0.02 72.78 PERIPHERAL COLDNESS | 2 0.02 72.80 PERIPHERAL ISCHAEMIA | 2 0.02 72.82 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 72.83 PERIPORTAL OEDEMA | 1 0.01 72.84 PERIRECTAL ABSCESS | 1 0.01 72.85 PERITONEAL DIALYSIS COMPLICATION | 2 0.02 72.87 PERITONITIS | 10 0.10 72.97 PERITONITIS BACTERIAL | 3 0.03 73.00 PERONEAL NERVE PALSY | 1 0.01 73.01 PERSECUTORY DELUSION | 1 0.01 73.02 PERSONALITY CHANGE | 2 0.02 73.04 PERSONALITY DISORDER | 1 0.01 73.05 PETECHIAE | 4 0.04 73.09 PETIT MAL EPILEPSY | 2 0.02 73.11 PHARYNGEAL OEDEMA | 2 0.02 73.13 PHARYNGITIS | 1 0.01 73.14 PHARYNGITIS STREPTOCOCCAL | 1 0.01 73.15 PHOTOPHOBIA | 1 0.01 73.16 PHOTOPSIA | 2 0.02 73.18 PHOTOSENSITIVITY REACTION | 2 0.02 73.20 PHYSIOTHERAPY | 1 0.01 73.21 PIGMENTATION DISORDER | 1 0.01 73.22 PLASMACYTOSIS | 1 0.01 73.23 PLASMAPHERESIS | 1 0.01 73.24 PLATELET COUNT DECREASED | 10 0.10 73.34 PLATELET COUNT INCREASED | 2 0.02 73.36 PLEOCYTOSIS | 1 0.01 73.37 PLEURAL EFFUSION | 14 0.14 73.51 PLEURISY | 2 0.02 73.53 PLEURITIC PAIN | 1 0.01 73.54 PNEUMOCOCCAL SEPSIS | 1 0.01 73.55 PNEUMOCYSTIS JIROVECI PNEUMONIA | 1 0.01 73.56 PNEUMONIA | 50 0.50 74.06 PNEUMONIA ASPIRATION | 1 0.01 74.07 PNEUMONIA BACTERIAL | 1 0.01 74.08 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 74.09 PNEUMONIA FUNGAL | 1 0.01 74.10 PNEUMONIA KLEBSIELLA | 2 0.02 74.12 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 74.13 PNEUMONITIS | 1 0.01 74.14 PNEUMOPERITONEUM | 1 0.01 74.15 PNEUMOTHORAX | 2 0.02 74.17 POIKILOCYTOSIS | 1 0.01 74.18 POISONING | 1 0.01 74.19 POLLAKIURIA | 6 0.06 74.25 POLYCHROMASIA | 2 0.02 74.27 POLYCYSTIC OVARIES | 1 0.01 74.28 POLYDACTYLY | 3 0.03 74.31 POLYDIPSIA | 2 0.02 74.33 POLYHYDRAMNIOS | 1 0.01 74.34 POLYMYALGIA RHEUMATICA | 2 0.02 74.36 POLYNEUROPATHY | 2 0.02 74.38 POLYP | 3 0.03 74.41 POLYURIA | 2 0.02 74.43 POOR QUALITY DRUG ADMINISTERED | 3 0.03 74.46 POOR QUALITY SLEEP | 2 0.02 74.48 POOR VENOUS ACCESS | 4 0.04 74.52 POST CONCUSSION SYNDROME | 1 0.01 74.53 POST HERPETIC NEURALGIA | 2 0.02 74.55 POST PROCEDURAL HAEMORRHAGE | 2 0.02 74.57 POST PROCEDURAL INFECTION | 1 0.01 74.58 POST-TRAUMATIC STRESS DISORDER | 2 0.02 74.60 POSTERIOR CAPSULE OPACIFICATION | 1 0.01 74.61 POSTICTAL HEADACHE | 1 0.01 74.62 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 74.63 POSTURE ABNORMAL | 1 0.01 74.64 PRE-ECLAMPSIA | 1 0.01 74.65 PREGNANCY | 8 0.08 74.73 PREGNANCY WITH CONTRACEPTIVE DEVICE | 1 0.01 74.74 PREMATURE BABY | 6 0.06 74.80 PREMATURE LABOUR | 1 0.01 74.81 PREMENSTRUAL SYNDROME | 1 0.01 74.82 PRESYNCOPE | 4 0.04 74.86 PRIAPISM | 1 0.01 74.87 PROCEDURAL COMPLICATION | 1 0.01 74.88 PROCEDURAL PAIN | 2 0.02 74.90 PROCTITIS | 2 0.02 74.92 PRODUCT ADHESION ISSUE | 4 0.04 74.96 PRODUCT COUNTERFEIT | 1 0.01 74.97 PRODUCT MEASURED POTENCY ISSUE | 2 0.02 74.99 PRODUCT ODOUR ABNORMAL | 1 0.01 75.00 PRODUCT PACKAGING ISSUE | 2 0.02 75.02 PRODUCT QUALITY ISSUE | 23 0.23 75.25 PRODUCT SOLUBILITY ABNORMAL | 1 0.01 75.26 PRODUCT TASTE ABNORMAL | 1 0.01 75.27 PRODUCTIVE COUGH | 4 0.04 75.31 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 4 0.04 75.35 PROSTATE CANCER | 1 0.01 75.36 PROSTATE CANCER RECURRENT | 1 0.01 75.37 PROSTATIC DISORDER | 1 0.01 75.38 PROSTATIC SPECIFIC ANTIGEN INCREASED | 3 0.03 75.41 PROSTATOMEGALY | 1 0.01 75.42 PROTEIN TOTAL DECREASED | 1 0.01 75.43 PROTEINURIA | 4 0.04 75.47 PROTHROMBIN TIME PROLONGED | 3 0.03 75.50 PRURITUS | 29 0.29 75.79 PRURITUS GENERALISED | 4 0.04 75.83 PSEUDOMEMBRANOUS COLITIS | 1 0.01 75.84 PSEUDOMONAL SEPSIS | 1 0.01 75.85 PSEUDOMONAS INFECTION | 1 0.01 75.86 PSEUDOMONAS TEST POSITIVE | 1 0.01 75.87 PSORIASIS | 2 0.02 75.89 PSORIATIC ARTHROPATHY | 1 0.01 75.90 PSYCHIATRIC SYMPTOM | 1 0.01 75.91 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 75.93 PSYCHOTIC DISORDER | 9 0.09 76.02 PUBIS FRACTURE | 2 0.02 76.04 PULMONARY ARTERIAL HYPERTENSION | 2 0.02 76.06 PULMONARY ARTERIOPATHY | 1 0.01 76.07 PULMONARY CONGESTION | 3 0.03 76.10 PULMONARY EMBOLISM | 14 0.14 76.24 PULMONARY FIBROSIS | 3 0.03 76.27 PULMONARY HAEMORRHAGE | 4 0.04 76.31 PULMONARY HILUM MASS | 1 0.01 76.32 PULMONARY HYPERTENSION | 3 0.03 76.35 PULMONARY INFARCTION | 2 0.02 76.37 PULMONARY OEDEMA | 10 0.10 76.47 PULMONARY TUBERCULOSIS | 1 0.01 76.48 PULMONARY VEIN OCCLUSION | 1 0.01 76.49 PULMONARY VENO-OCCLUSIVE DISEASE | 1 0.01 76.50 PULSE ABSENT | 1 0.01 76.51 PUNCTURE SITE INFECTION | 1 0.01 76.52 PUPILS UNEQUAL | 1 0.01 76.53 PURPURA | 3 0.03 76.56 PURULENCE | 2 0.02 76.58 PURULENT DISCHARGE | 2 0.02 76.60 PYELOCALIECTASIS | 1 0.01 76.61 PYELONEPHRITIS | 2 0.02 76.63 PYLORIC STENOSIS | 1 0.01 76.64 PYODERMA GANGRENOSUM | 3 0.03 76.67 PYOGENIC GRANULOMA | 1 0.01 76.68 PYREXIA | 47 0.47 77.15 QUADRIPARESIS | 3 0.03 77.18 RADIATION INJURY | 1 0.01 77.19 RADIATION PNEUMONITIS | 1 0.01 77.20 RADICULITIS BRACHIAL | 1 0.01 77.21 RADICULITIS LUMBOSACRAL | 1 0.01 77.22 RADIOTHERAPY | 2 0.02 77.24 RADIUS FRACTURE | 1 0.01 77.25 RALES | 1 0.01 77.26 RASH | 28 0.28 77.54 RASH ERYTHEMATOUS | 6 0.06 77.60 RASH GENERALISED | 9 0.09 77.69 RASH MACULAR | 7 0.07 77.76 RASH MACULO-PAPULAR | 3 0.03 77.79 RASH MORBILLIFORM | 1 0.01 77.80 RASH PAPULAR | 6 0.06 77.86 RASH PAPULOSQUAMOUS | 1 0.01 77.87 RASH PRURITIC | 5 0.05 77.92 RASH PUSTULAR | 3 0.03 77.95 RASH VESICULAR | 1 0.01 77.96 RAYNAUD'S PHENOMENON | 1 0.01 77.97 REACTION TO DRUG EXCIPIENTS | 1 0.01 77.98 READING DISORDER | 1 0.01 77.99 RECTAL ADENOMA | 1 0.01 78.00 RECTAL FISSURE | 1 0.01 78.01 RECTAL HAEMORRHAGE | 4 0.04 78.05 RED BLOOD CELL COUNT ABNORMAL | 1 0.01 78.06 RED BLOOD CELL COUNT DECREASED | 4 0.04 78.10 RED BLOOD CELL COUNT INCREASED | 1 0.01 78.11 RED BLOOD CELL SEDIMENTATION RATE INC.. | 3 0.03 78.14 RED CELL DISTRIBUTION WIDTH INCREASED | 3 0.03 78.17 REFLUX LARYNGITIS | 1 0.01 78.18 REFLUX NEPHROPATHY | 1 0.01 78.19 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 78.21 RENAL ARTERY STENOSIS | 1 0.01 78.22 RENAL CANCER | 1 0.01 78.23 RENAL CANCER STAGE III | 1 0.01 78.24 RENAL COLIC | 4 0.04 78.28 RENAL CYST | 1 0.01 78.29 RENAL DISORDER | 4 0.04 78.33 RENAL FAILURE | 291 2.91 81.24 RENAL FAILURE ACUTE | 53 0.53 81.77 RENAL FAILURE CHRONIC | 6 0.06 81.83 RENAL HAEMORRHAGE | 2 0.02 81.85 RENAL IMPAIRMENT | 233 2.33 84.18 RENAL INJURY | 228 2.28 86.46 RENAL MASS | 1 0.01 86.47 RENAL PAIN | 1 0.01 86.48 RESPIRATORY ACIDOSIS | 1 0.01 86.49 RESPIRATORY ARREST | 4 0.04 86.53 RESPIRATORY DEPRESSION | 1 0.01 86.54 RESPIRATORY DISORDER | 4 0.04 86.58 RESPIRATORY DISTRESS | 3 0.03 86.61 RESPIRATORY FAILURE | 16 0.16 86.77 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 86.78 RESPIRATORY TRACT INFECTION | 3 0.03 86.81 RESPIRATORY TRACT INFECTION BACTERIAL | 1 0.01 86.82 RESTLESS LEGS SYNDROME | 2 0.02 86.84 RESTLESSNESS | 6 0.06 86.90 RETCHING | 2 0.02 86.92 RETICULOCYTE COUNT INCREASED | 1 0.01 86.93 RETINAL ANEURYSM | 1 0.01 86.94 RETINAL ARTERY THROMBOSIS | 1 0.01 86.95 RETINAL DETACHMENT | 2 0.02 86.97 RETINAL DISORDER | 1 0.01 86.98 RETINAL HAEMORRHAGE | 5 0.05 87.03 RETINAL TEAR | 1 0.01 87.04 RETINAL VEIN OCCLUSION | 1 0.01 87.05 RETROGRADE EJACULATION | 1 0.01 87.06 REVERSIBLE POSTERIOR LEUKOENCEPHALOPA.. | 2 0.02 87.08 RHABDOMYOLYSIS | 5 0.05 87.13 RHEUMATOID ARTHRITIS | 14 0.14 87.27 RHINITIS | 3 0.03 87.30 RHINITIS ALLERGIC | 1 0.01 87.31 RHINORRHOEA | 5 0.05 87.36 RHONCHI | 1 0.01 87.37 RIB FRACTURE | 4 0.04 87.41 RIGHT VENTRICULAR FAILURE | 1 0.01 87.42 ROAD TRAFFIC ACCIDENT | 6 0.06 87.48 ROTATOR CUFF REPAIR | 1 0.01 87.49 ROTATOR CUFF SYNDROME | 5 0.05 87.54 SALIVARY HYPERSECRETION | 1 0.01 87.55 SALMONELLOSIS | 1 0.01 87.56 SALPINGO-OOPHORECTOMY | 1 0.01 87.57 SARCOIDOSIS | 1 0.01 87.58 SCAB | 1 0.01 87.59 SCAPULA FRACTURE | 1 0.01 87.60 SCAR | 6 0.06 87.66 SCHIZOAFFECTIVE DISORDER | 1 0.01 87.67 SCHIZOPHRENIA | 3 0.03 87.70 SCHIZOTYPAL PERSONALITY DISORDER | 1 0.01 87.71 SCIATIC NERVE NEUROPATHY | 1 0.01 87.72 SCIATICA | 2 0.02 87.74 SCOLIOSIS | 1 0.01 87.75 SCREAMING | 1 0.01 87.76 SCROTAL OEDEMA | 1 0.01 87.77 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 87.78 SEDATION | 2 0.02 87.80 SELF INJURIOUS BEHAVIOUR | 1 0.01 87.81 SELF-INJURIOUS IDEATION | 1 0.01 87.82 SENILE DEMENTIA | 1 0.01 87.83 SENILE OSTEOPOROSIS | 1 0.01 87.84 SENSATION OF HEAVINESS | 4 0.04 87.88 SENSORY DISTURBANCE | 2 0.02 87.90 SENSORY LOSS | 2 0.02 87.92 SEPSIS | 22 0.22 88.14 SEPTIC ARTHRITIS STAPHYLOCOCCAL | 1 0.01 88.15 SEPTIC SHOCK | 2 0.02 88.17 SEROCONVERSION TEST POSITIVE | 1 0.01 88.18 SEROTONIN SYNDROME | 2 0.02 88.20 SERUM FERRITIN INCREASED | 1 0.01 88.21 SHOCK | 3 0.03 88.24 SHOULDER OPERATION | 1 0.01 88.25 SIALOADENITIS | 1 0.01 88.26 SICKLE CELL ANAEMIA | 1 0.01 88.27 SINUS ARREST | 1 0.01 88.28 SINUS CONGESTION | 1 0.01 88.29 SINUS HEADACHE | 1 0.01 88.30 SINUS OPERATION | 1 0.01 88.31 SINUS POLYP | 1 0.01 88.32 SINUS TACHYCARDIA | 4 0.04 88.36 SINUSITIS | 7 0.07 88.43 SKELETAL INJURY | 1 0.01 88.44 SKIN ATROPHY | 2 0.02 88.46 SKIN BURNING SENSATION | 2 0.02 88.48 SKIN CANCER | 1 0.01 88.49 SKIN DISCOLOURATION | 5 0.05 88.54 SKIN DISORDER | 3 0.03 88.57 SKIN EXFOLIATION | 11 0.11 88.68 SKIN FIBROSIS | 4 0.04 88.72 SKIN GRAFT | 1 0.01 88.73 SKIN HAEMORRHAGE | 1 0.01 88.74 SKIN HYPERPIGMENTATION | 4 0.04 88.78 SKIN HYPERTROPHY | 5 0.05 88.83 SKIN INDURATION | 5 0.05 88.88 SKIN IRRITATION | 1 0.01 88.89 SKIN LACERATION | 2 0.02 88.91 SKIN LESION | 9 0.09 89.00 SKIN NECROSIS | 2 0.02 89.02 SKIN ODOUR ABNORMAL | 1 0.01 89.03 SKIN OEDEMA | 1 0.01 89.04 SKIN PAPILLOMA | 3 0.03 89.07 SKIN PLAQUE | 2 0.02 89.09 SKIN REACTION | 1 0.01 89.10 SKIN TIGHTNESS | 3 0.03 89.13 SKIN TOXICITY | 1 0.01 89.14 SKIN ULCER | 8 0.08 89.22 SKIN ULCER HAEMORRHAGE | 1 0.01 89.23 SLEEP APNOEA SYNDROME | 3 0.03 89.26 SLEEP DISORDER | 4 0.04 89.30 SMALL FOR DATES BABY | 1 0.01 89.31 SMALL INTESTINAL PERFORATION | 1 0.01 89.32 SMALL INTESTINAL RESECTION | 1 0.01 89.33 SNEEZING | 1 0.01 89.34 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 89.35 SOCIAL FEAR | 1 0.01 89.36 SOFT TISSUE INFLAMMATION | 1 0.01 89.37 SOMNOLENCE | 24 0.24 89.61 SOPOR | 1 0.01 89.62 SPEECH DISORDER | 8 0.08 89.70 SPEECH DISORDER DEVELOPMENTAL | 7 0.07 89.77 SPINAL COLUMN STENOSIS | 3 0.03 89.80 SPINAL FRACTURE | 2 0.02 89.82 SPINAL FUSION SURGERY | 1 0.01 89.83 SPINAL OPERATION | 1 0.01 89.84 SPINAL OSTEOARTHRITIS | 3 0.03 89.87 SPLEEN DISORDER | 1 0.01 89.88 SPLENECTOMY | 1 0.01 89.89 SPLENIC HAEMORRHAGE | 1 0.01 89.90 SPLENIC INFARCTION | 1 0.01 89.91 SPLENOMEGALY | 3 0.03 89.94 SPONDYLOLISTHESIS | 1 0.01 89.95 SQUAMOUS CELL CARCINOMA | 2 0.02 89.97 SQUAMOUS CELL CARCINOMA OF SKIN | 2 0.02 89.99 STAPHYLOCOCCAL IMPETIGO | 1 0.01 90.00 STAPHYLOCOCCAL INFECTION | 4 0.04 90.04 STAPHYLOCOCCAL SEPSIS | 2 0.02 90.06 STAPHYLOCOCCAL SKIN INFECTION | 1 0.01 90.07 STAPHYLOCOCCUS TEST POSITIVE | 1 0.01 90.08 STEATORRHOEA | 1 0.01 90.09 STEM CELL TRANSPLANT | 2 0.02 90.11 STEVENS-JOHNSON SYNDROME | 7 0.07 90.18 STOMATITIS | 4 0.04 90.22 STRESS | 75 0.75 90.97 STRESS URINARY INCONTINENCE | 1 0.01 90.98 STRONGYLOIDIASIS | 2 0.02 91.00 STUPOR | 1 0.01 91.01 SUBARACHNOID HAEMORRHAGE | 2 0.02 91.03 SUBCUTANEOUS HAEMATOMA | 1 0.01 91.04 SUBENDOCARDIAL ISCHAEMIA | 1 0.01 91.05 SUBSTANCE ABUSE | 2 0.02 91.07 SUDDEN CARDIAC DEATH | 1 0.01 91.08 SUDDEN DEATH | 2 0.02 91.10 SUDDEN HEARING LOSS | 1 0.01 91.11 SUICIDAL IDEATION | 19 0.19 91.30 SUICIDE ATTEMPT | 12 0.12 91.42 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 91.43 SURGERY | 5 0.05 91.48 SWELLING | 10 0.10 91.58 SWELLING FACE | 6 0.06 91.64 SWOLLEN TONGUE | 3 0.03 91.67 SYNCOPE | 19 0.19 91.86 SYNOVIAL CYST | 2 0.02 91.88 SYNOVIAL RUPTURE | 1 0.01 91.89 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 2 0.02 91.91 SYSTEMIC LUPUS ERYTHEMATOSUS | 2 0.02 91.93 T-CELL LYMPHOMA | 1 0.01 91.94 TACHYCARDIA | 13 0.13 92.07 TACHYPNOEA | 5 0.05 92.12 TEMPORAL LOBE EPILEPSY | 1 0.01 92.13 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 92.14 TENDON DISORDER | 1 0.01 92.15 TENDON INJURY | 1 0.01 92.16 TENDON PAIN | 3 0.03 92.19 TENDON RUPTURE | 9 0.09 92.28 TENDONITIS | 5 0.05 92.33 TENOSYNOVITIS | 3 0.03 92.36 TENSION | 4 0.04 92.40 THERAPEUTIC AGENT TOXICITY | 1 0.01 92.41 THERAPEUTIC RESPONSE DECREASED | 4 0.04 92.45 THERAPEUTIC RESPONSE UNEXPECTED | 3 0.03 92.48 THERAPY CESSATION | 1 0.01 92.49 THERMAL BURN | 1 0.01 92.50 THINKING ABNORMAL | 3 0.03 92.53 THIRST | 3 0.03 92.56 THIRST DECREASED | 1 0.01 92.57 THORACIC VERTEBRAL FRACTURE | 1 0.01 92.58 THROAT IRRITATION | 6 0.06 92.64 THROAT TIGHTNESS | 4 0.04 92.68 THROMBOCYTOPENIA | 20 0.20 92.88 THROMBOPHLEBITIS | 1 0.01 92.89 THROMBOSIS | 9 0.09 92.98 THROMBOTIC STROKE | 1 0.01 92.99 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 93.00 THYROID CANCER | 3 0.03 93.03 THYROID DISORDER | 2 0.02 93.05 THYROID NEOPLASM | 1 0.01 93.06 TINNITUS | 5 0.05 93.11 TOBACCO ABUSE | 1 0.01 93.12 TONGUE OEDEMA | 1 0.01 93.13 TONGUE ULCERATION | 1 0.01 93.14 TONIC CLONIC MOVEMENTS | 1 0.01 93.15 TOOTH ABSCESS | 1 0.01 93.16 TOOTH DISCOLOURATION | 1 0.01 93.17 TOOTH DISORDER | 4 0.04 93.21 TOOTH EXTRACTION | 5 0.05 93.26 TOOTH INFECTION | 2 0.02 93.28 TOOTH INJURY | 1 0.01 93.29 TOOTHACHE | 2 0.02 93.31 TORTICOLLIS | 2 0.02 93.33 TOXIC ENCEPHALOPATHY | 1 0.01 93.34 TOXIC EPIDERMAL NECROLYSIS | 2 0.02 93.36 TOXOPLASMOSIS | 1 0.01 93.37 TRACHEOSTOMY | 1 0.01 93.38 TRANSAMINASES INCREASED | 3 0.03 93.41 TRANSIENT GLOBAL AMNESIA | 1 0.01 93.42 TRANSIENT ISCHAEMIC ATTACK | 6 0.06 93.48 TRANSURETHRAL PROSTATECTOMY | 1 0.01 93.49 TREATMENT FAILURE | 1 0.01 93.50 TREATMENT NONCOMPLIANCE | 5 0.05 93.55 TREMOR | 28 0.28 93.83 TRICUSPID VALVE INCOMPETENCE | 1 0.01 93.84 TRIGEMINAL NEURALGIA | 1 0.01 93.85 TRIGGER FINGER | 1 0.01 93.86 TROPONIN INCREASED | 1 0.01 93.87 TROPONIN T INCREASED | 1 0.01 93.88 TUBERCULOSIS | 1 0.01 93.89 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 93.91 TUMOUR LYSIS SYNDROME | 2 0.02 93.93 TYPE 1 DIABETES MELLITUS | 1 0.01 93.94 TYPE 2 DIABETES MELLITUS | 17 0.17 94.11 TYPE I HYPERSENSITIVITY | 1 0.01 94.12 ULCER | 6 0.06 94.18 ULCER HAEMORRHAGE | 1 0.01 94.19 ULCERATIVE KERATITIS | 1 0.01 94.20 ULNA FRACTURE | 1 0.01 94.21 ULTRASOUND ANTENATAL SCREEN ABNORMAL | 1 0.01 94.22 UMBILICAL HERNIA | 1 0.01 94.23 UNEVALUABLE EVENT | 224 2.24 96.47 UNINTENDED PREGNANCY | 6 0.06 96.53 UNRESPONSIVE TO STIMULI | 6 0.06 96.59 UPPER EXTREMITY MASS | 1 0.01 96.60 UPPER GASTROINTESTINAL HAEMORRHAGE | 3 0.03 96.63 UPPER LIMB FRACTURE | 6 0.06 96.69 UPPER RESPIRATORY FUNGAL INFECTION | 1 0.01 96.70 UPPER RESPIRATORY TRACT INFECTION | 4 0.04 96.74 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 96.75 URETERIC OBSTRUCTION | 1 0.01 96.76 URETHRAL DILATATION | 1 0.01 96.77 URETHRAL OPERATION | 1 0.01 96.78 URETHRAL STENOSIS | 1 0.01 96.79 URINARY INCONTINENCE | 3 0.03 96.82 URINARY NITROGEN INCREASED | 1 0.01 96.83 URINARY RETENTION | 3 0.03 96.86 URINARY TRACT DISORDER | 2 0.02 96.88 URINARY TRACT INFECTION | 18 0.18 97.06 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 97.07 URINARY TRACT OBSTRUCTION | 1 0.01 97.08 URINE ANALYSIS ABNORMAL | 2 0.02 97.10 URINE COLOUR ABNORMAL | 1 0.01 97.11 URINE FLOW DECREASED | 1 0.01 97.12 URINE OUTPUT DECREASED | 1 0.01 97.13 URINE OUTPUT INCREASED | 1 0.01 97.14 UROSEPSIS | 2 0.02 97.16 UROSTOMY | 1 0.01 97.17 URTICARIA | 17 0.17 97.34 UTERINE CANCER | 1 0.01 97.35 UTERINE DISORDER | 1 0.01 97.36 UTERINE INFECTION | 1 0.01 97.37 UTERINE MALPOSITION | 1 0.01 97.38 UTERINE POLYP | 1 0.01 97.39 VAGINAL HAEMORRHAGE | 5 0.05 97.44 VAGINAL INFLAMMATION | 1 0.01 97.45 VARICES OESOPHAGEAL | 1 0.01 97.46 VASCULAR GRAFT COMPLICATION | 1 0.01 97.47 VASCULAR SHUNT | 1 0.01 97.48 VASCULITIS | 1 0.01 97.49 VEIN DISORDER | 2 0.02 97.51 VENOOCCLUSIVE DISEASE | 2 0.02 97.53 VENOUS THROMBOSIS LIMB | 1 0.01 97.54 VENTRICULAR FIBRILLATION | 2 0.02 97.56 VENTRICULAR HYPOKINESIA | 1 0.01 97.57 VENTRICULAR SEPTAL DEFECT | 2 0.02 97.59 VENTRICULAR TACHYCARDIA | 2 0.02 97.61 VERTEBROPLASTY | 1 0.01 97.62 VERTIGO | 6 0.06 97.68 VIITH NERVE PARALYSIS | 4 0.04 97.72 VIRAL INFECTION | 4 0.04 97.76 VIRAL PHARYNGITIS | 1 0.01 97.77 VISION BLURRED | 20 0.20 97.97 VISUAL ACUITY REDUCED | 5 0.05 98.02 VISUAL BRIGHTNESS | 1 0.01 98.03 VISUAL IMPAIRMENT | 17 0.17 98.20 VITAMIN B12 DECREASED | 2 0.02 98.22 VITAMIN B12 DEFICIENCY | 2 0.02 98.24 VITAMIN D DECREASED | 3 0.03 98.27 VITAMIN D DEFICIENCY | 2 0.02 98.29 VITREOUS DETACHMENT | 2 0.02 98.31 VITREOUS FLOATERS | 3 0.03 98.34 VITREOUS HAEMORRHAGE | 2 0.02 98.36 VOCAL CORD THICKENING | 1 0.01 98.37 VOMITING | 54 0.54 98.91 VOMITING PROJECTILE | 1 0.01 98.92 VULVOVAGINAL CANDIDIASIS | 1 0.01 98.93 VULVOVAGINAL DRYNESS | 2 0.02 98.95 VULVOVAGINAL MYCOTIC INFECTION | 2 0.02 98.97 WEIGHT DECREASED | 20 0.20 99.17 WEIGHT FLUCTUATION | 1 0.01 99.18 WEIGHT INCREASED | 20 0.20 99.38 WHEEZING | 8 0.08 99.46 WHITE BLOOD CELL COUNT DECREASED | 11 0.11 99.57 WHITE BLOOD CELL COUNT INCREASED | 9 0.09 99.66 WHITE BLOOD CELL DISORDER | 1 0.01 99.67 WITHDRAWAL SYNDROME | 7 0.07 99.74 WOUND CONTAMINATION | 1 0.01 99.75 WOUND DEHISCENCE | 1 0.01 99.76 WOUND DRAINAGE | 1 0.01 99.77 WOUND HAEMORRHAGE | 2 0.02 99.79 WRIST DEFORMITY | 1 0.01 99.80 WRIST FRACTURE | 1 0.01 99.81 WRONG DRUG ADMINISTERED | 2 0.02 99.83 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 13 0.13 99.96 X-RAY | 1 0.01 99.97 X-RAY ABNORMAL | 1 0.01 99.98 XANTHOCHROMIA | 1 0.01 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015